<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2024.1402589</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Transcriptome profiling of macrophages persistently infected with human respiratory syncytial virus and effect of recombinant <italic>Taenia solium</italic> calreticulin on immune-related genes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Rivera-Toledo</surname> <given-names>Evelyn</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1845920/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Fern&#x00E1;ndez-Rojas</surname> <given-names>Miguel A.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2695658/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Santiago-Olivares</surname> <given-names>Carlos</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2230860/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Cruz-Rivera</surname> <given-names>Mayra</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/523568/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Hern&#x00E1;ndez-Bautista</surname> <given-names>Vania</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2700086/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>&#x00C1;vila-Horta</surname> <given-names>Fernanda</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2764949/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Flisser</surname> <given-names>Ana</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Mendlovic</surname> <given-names>Fela</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1215750/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Departamento de Microbiolog&#x00ED;a y Parasitolog&#x00ED;a, Facultad de Medicina, Universidad Nacional Aut&#x00F3;noma de M&#x00E9;xico (UNAM)</institution>, <addr-line>Mexico City</addr-line>, <country>Mexico</country></aff>
<aff id="aff2"><sup>2</sup><institution>Facultad de Ciencias de la Salud, Universidad An&#x00E1;huac M&#x00E9;xico Norte</institution>, <addr-line>Huixquilucan de Degollado</addr-line>, <country>Mexico</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0001">
<p>Edited by: Juan C. Hernandez, Cooperative University of Colombia, Colombia</p>
</fn>
<fn fn-type="edited-by" id="fn0002">
<p>Reviewed by: Engin Berber, Cleveland Clinic, United States</p>
<p>A. Raj Kumar Patro, Kalinga Institute of Medical Sciences (KIMS), India</p>
</fn>
<corresp id="c001">&#x002A;Correspondence: Fela Mendlovic, <email>fmendlo@yahoo.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>04</day>
<month>09</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1402589</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>03</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>08</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2024 Rivera-Toledo, Fern&#x00E1;ndez-Rojas, Santiago-Olivares, Cruz-Rivera, Hern&#x00E1;ndez-Bautista, &#x00C1;vila-Horta, Flisser and Mendlovic.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Rivera-Toledo, Fern&#x00E1;ndez-Rojas, Santiago-Olivares, Cruz-Rivera, Hern&#x00E1;ndez-Bautista, &#x00C1;vila-Horta, Flisser and Mendlovic</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>Human respiratory syncytial virus (hRSV) is a main cause of bronchiolitis in infants and its persistence has been described in immunocompromised subjects. However, limited evidence has been reported on the gene expression triggered by the hRSV and the effect of recombinant <italic>Taenia solium</italic>-derived calreticulin (rTsCRT).</p>
</sec>
<sec>
<title>Methods</title>
<p>Using a comprehensive microarray approach, we analyzed the transcriptome profile of a macrophage cell line that has supported hRSV persistence for over 150 passages. We compared the gene expression of persistently infected and non-infected macrophages. We also evaluated the effect of rTsCRT on hRSV-infected macrophage gene transcription, as well as on cytokine production and number of copies of the persistent hRSV genome.</p>
</sec>
<sec>
<title>Results</title>
<p>Our analysis showed that hRSV long-term virus infection significantly alters mRNA expression of antiviral, inflammatory, as well as arginine and lipid metabolism-associated genes, revealing a transcriptional signature that suggests a mixed M1/M2 phenotype. The resulting host-virus equilibrium allows for the regulation of viral replication, while evading the antiviral and proinflammatory responses. Interestingly, rTsCRT stimulus upregulated <italic>Tnf&#x03B1;</italic>, <italic>Il6</italic> and <italic>Nos2</italic> mRNA. We found increased levels of both proinflammatory cytokines and nitrite levels in the conditioned media of persistent macrophages treated with rTsCRT. This increase was associated with a significant reduction in viral genome copies.</p>
</sec>
<sec>
<title>Discussion</title>
<p>hRSV persistently infected macrophages retain responsiveness to external stimuli and demonstrate that the profound changes induced by viral persistence are potentially reversible. Our observations contribute to the understanding of the mechanisms related to hRSV persistence in macrophages and have implications for the development of targeted therapies to eliminate persistent infections or reduce the negative effects related with chronic inflammatory diseases associated with hRSV infection.</p>
</sec>
</abstract>
<kwd-group>
<kwd>P388D1 cell line</kwd>
<kwd>viral persistence</kwd>
<kwd>antiviral activity</kwd>
<kwd>calreticulin</kwd>
<kwd>HRSV</kwd>
</kwd-group>
<contract-num rid="cn1">PAPIIT IN208420</contract-num>
<contract-sponsor id="cn1">Direcci&#x00F3;n General de Asuntos Personal Acad&#x00E9;mico (DGAPA), Universidad Nacional Aut&#x00F3;noma de M&#x00E9;xico (UNAM), Mexico</contract-sponsor>
<counts>
<fig-count count="7"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="93"/>
<page-count count="16"/>
<word-count count="11264"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Virology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec1">
<label>1</label>
<title>Introduction</title>
<p>Human respiratory syncytial virus (hRSV) is a leading cause of bronchiolitis and pneumonia in infants and is linked to the development of airway hyperreactivity in children who suffer severe disease early in life (<xref ref-type="bibr" rid="ref67">Rosas-Salazar et al., 2023</xref>). hRSV infection in the elderly is also of concern, as the incidence of mortality may exceed that estimated for infants by a factor of 20 (<xref ref-type="bibr" rid="ref11">Coultas et al., 2019</xref>).</p>
<p>hRSV is an enveloped virus belonging to the <italic>Pneumoviridae</italic> family, Orthopneumovirus genus. It possesses a single-stranded negative sense RNA genome and contains 10 genes that encode for 11 proteins (<xref ref-type="bibr" rid="ref3">Battles and McLellan, 2019</xref>). Viral PAMPs (pathogen associated molecular patterns), like proteins and single-stranded or double-stranded RNA (ssRNA or dsRNA) trigger signaling pathways that activate transcription factors such as interferon regulatory factors (IRFs), NF-&#x03BA;B, ATF2 and c-Jun to establish an antiviral and proinflammatory state (<xref ref-type="bibr" rid="ref35">Kawai and Akira, 2006</xref>; <xref ref-type="bibr" rid="ref9">Carty et al., 2021</xref>). Particularly, hRSV nucleic acids are recognized through RLRs (ddx58/RIG-I and Ifih1/MDA5), TLR3, TLR7 and TLR8, while proteins are detected by TLR2, TLR6 and TLR4 (<xref ref-type="bibr" rid="ref53">Ouyang et al., 2022</xref>).</p>
<p>Proinflammatory cytokines and chemokines that recruit leukocytes are produced during hRSV infection and contribute to viral clearance. However, in younger infants hRSV, severe disease is associated with a deregulated inflammatory response associated with the development of recurrent wheezing and asthma-like symptoms (<xref ref-type="bibr" rid="ref65">Roe et al., 2011</xref>; <xref ref-type="bibr" rid="ref69">Russell et al., 2017</xref>). The mechanisms linked to these respiratory complications are not clear. However, they appear to be multifactorial, involving factors such as age, host-genetic predisposition, immune responses, and the virus&#x2019;s ability to establish persistent infections (<xref ref-type="bibr" rid="ref4">Bertrand et al., 2015</xref>; <xref ref-type="bibr" rid="ref7">Bont and Ramilo, 2011</xref>; <xref ref-type="bibr" rid="ref34">Kato et al., 2012</xref>; <xref ref-type="bibr" rid="ref47">Mej&#x00ED;as et al., 2005</xref>; <xref ref-type="bibr" rid="ref57">Piedimonte and Perez, 2014</xref>; <xref ref-type="bibr" rid="ref91">Wu and Hartert, 2011</xref>).</p>
<p>hRSV persistence has been described in the respiratory tract of immunocompromised subjects and in mouse models (<xref ref-type="bibr" rid="ref82">Tabatabai et al., 2018</xref>). hRSV genomic RNA and viral messenger RNA were detected for over 100&#x2009;days after primary infection in mice. Recovery of infectious virus occurred only after depletion of CD4 and CD8 T lymphocytes, suggesting that the immune response has an essential role in viral elimination (<xref ref-type="bibr" rid="ref79">Schwarze et al., 2004</xref>). Furthermore, hRSV persistence has been established in human epithelial cell lines and mouse macrophages (<xref ref-type="bibr" rid="ref44">Mart&#x00ED;nez et al., 2009</xref>; <xref ref-type="bibr" rid="ref76">Sarmiento et al., 2002</xref>; <xref ref-type="bibr" rid="ref86">Valdovinos and G&#x00F3;mez, 2003</xref>). Cell lines are a valuable tool to characterize the virus-host cell interactions responsible for the establishment and maintenance of long-term infections. The study of the mechanisms, consequences and possible therapeutic targets of long-term viral infections is fundamental, given the large number of chronic diseases associated with viral persistence.</p>
<p>The role of macrophages in hRSV infection is complex and depends on the cell phenotype, time post infection and interaction with other cells. Macrophage polarization is influenced by different mechanisms that include cytokine microenvironment and lipid metabolism. Recently, M1 polarization has been characterized by a high rate of glycolysis, whereas oxidative phosphorylation and fatty acid oxidation are characteristic of M2-like macrophages (<xref ref-type="bibr" rid="ref2">Batista-Gonzalez et al., 2020</xref>). Viruses often evolve to promote M2-like responses in order to survive in host cells (<xref ref-type="bibr" rid="ref74">Sang et al., 2015</xref>). In coculture experiments with human bronchial epithelial cells and blood derived macrophages, M2-like macrophages were shown to increase hRSV infection, while M1-like macrophages protected against epithelial infection (<xref ref-type="bibr" rid="ref66">Ronaghan et al., 2022</xref>).</p>
<p>We previously reported the ability of hRSV to persist for over 150 passages in the P388D1 mouse macrophage-like cell line (<xref ref-type="bibr" rid="ref76">Sarmiento et al., 2002</xref>; <xref ref-type="bibr" rid="ref68">Ruiz-G&#x00F3;mez et al., 2021</xref>) and showed that hRSV-persistently infected macrophages (piM&#x03D5;) have a predominantly proinflammatory profile or M1-like status. Indeed, conditioned medium from piM&#x03D5; can induce a proinflammatory/antiviral state in non-infected macrophages due to the presence of biologically active inflammatory cytokines and chemokines (<xref ref-type="bibr" rid="ref63">Rivera-Toledo et al., 2017</xref>). Nevertheless, arginase 1 (<italic>Arg-1</italic>), a marker of M2 polarization in macrophages, is highly expressed and shows increased enzymatic activity in piM&#x03D5;, which interferes with the production of nitric oxide (NO), a potent antiviral effector molecule (<xref ref-type="bibr" rid="ref75">Santiago-Olivares et al., 2019</xref>). This suggests that this M2 phenotype marker could contribute to viral persistence. It is not known whether hRSV persistence can induce the expression of other M2-associated genes.</p>
<p>Calreticulin (CRT) is a multifunctional and ubiquitous chaperone with canonical functions in the endoplasmic reticulum that include Ca++ homeostasis and correct glycoprotein folding (<xref ref-type="bibr" rid="ref21">Gelebart et al., 2005</xref>; <xref ref-type="bibr" rid="ref49">Michalak et al., 2009</xref>). However, CRT has also been reported outside the endoplasmic reticulum, in the cytoplasm, cell surface and extracellular space (<xref ref-type="bibr" rid="ref22">Gold et al., 2010</xref>). In addition to its housekeeping functions, CRT has gained much attention due to its strong immunomodulatory activities that range from anti-inflammatory to pro-inflammatory effects. CRT has been identified in a wide range of parasites and influences cell responses and host-pathogen interactions. Mammalian CRT and its fragments have been shown to be potent stimulators of macrophages, stimulating the production of proinflammatory cytokines (<xref ref-type="bibr" rid="ref15">Duo et al., 2014</xref>; <xref ref-type="bibr" rid="ref26">Hong et al., 2010</xref>; <xref ref-type="bibr" rid="ref16">Esperante et al., 2023</xref>; <xref ref-type="bibr" rid="ref28">Huang et al., 2013</xref>). Many of the immunomodulatory functions of mammalian CRT are mirrored by parasite CRT.</p>
<p>Helminths are parasites that have coevolved with their human host for millennia. This long-term interaction has resulted in helminth survival strategies that regulate the host immune response through immunomodulatory molecules (<xref ref-type="bibr" rid="ref20">Gazzinelli-Guimaraes and Nutman, 2018</xref>). A recent review by <xref ref-type="bibr" rid="ref71">Ryan et al. (2020)</xref> suggests that helminth-derived product represent a &#x201C;untapped pharmacopeia.&#x201D; CRT from several parasites has been studied in different disease scenarios such as cancer, immune evasion, immune response, vaccination, and immunomodulation (<xref ref-type="bibr" rid="ref16">Esperante et al., 2023</xref>; <xref ref-type="bibr" rid="ref41">L&#x00F3;pez et al., 2010</xref>; <xref ref-type="bibr" rid="ref72">Rzepecka et al., 2009</xref>; <xref ref-type="bibr" rid="ref90">Winter et al., 2005</xref>). Evidence suggests that CRT homologues exhibit comparable functions across different species. For example, CRT from different parasites can inhibit the complement system, thus facilitating their survival within the host (<xref ref-type="bibr" rid="ref16">Esperante et al., 2023</xref>; <xref ref-type="bibr" rid="ref59">Ram&#x00ED;rez-Toloza and Ferreira, 2017</xref>). Furthermore, both the protozoan parasite <italic>Trypanosoma cruzi</italic> CRT (TcCRT) and the helminth <italic>Taenia solium</italic> CRT (TsCRT) recombinant forms exhibit antitumoral properties (<xref ref-type="bibr" rid="ref41">L&#x00F3;pez et al., 2010</xref>; <xref ref-type="bibr" rid="ref77">Schcolnik-Cabrera et al., 2020</xref>).</p>
<p>However, TcCRT is more efficient in inhibiting the complement system and has a stronger antitumoral effect in comparison to human CRT (<xref ref-type="bibr" rid="ref41">L&#x00F3;pez et al., 2010</xref>; <xref ref-type="bibr" rid="ref58">Ram&#x00ED;rez-Toloza et al., 2020</xref>). The difference in efficiency can be attributed in part to conformational rearrangements based in species-specific structural features (<xref ref-type="bibr" rid="ref56">Pe&#x00F1;a &#x00C1;lvarez et al., 2020</xref>).</p>
<p>We previously cloned and expressed CRT from the helminth <italic>Taenia solium</italic> as a recombinant protein (rTsCRT) (<xref ref-type="bibr" rid="ref48">Mendlovic et al., 2004</xref>). Given the potential of mammalian CRT to activate macrophages, we hypothesized that rTsCRT can trigger a proinflammatory immune response in piM&#x03D5;, potentially leading to antiviral activity. In this study we analyzed the transcriptome profile of piM&#x03D5; with special emphasis on the antiviral and inflammatory responses, as well as on arginine and lipid metabolisms. We examined different time points after initiation of macrophage culture to identify early and late onset genes. In addition, we investigated the effects of rTsCRT treatment on the viral load and transcriptional signature induced by persistent hRSV infection.</p>
</sec>
<sec sec-type="materials|methods" id="sec2">
<label>2</label>
<title>Materials and methods</title>
<sec id="sec3">
<label>2.1</label>
<title>Cell culture</title>
<p>The mouse macrophage-like P388D1 cell line obtained from the American Type Culture Collection (TIB-63, ATCC, Manassas, VA, United States) was acutely infected with the hRSV strain Long (VR-26, ATCC, Manassas, VA, United States) at a multiplicity of infection of 1 (M.O.I. 1). Surviving cells were cultured to establish the piM&#x03D5;, as previously described (<xref ref-type="bibr" rid="ref76">Sarmiento et al., 2002</xref>). The piM&#x03D5; were maintained in RPMI-1640 (Gibco, Thermo Fisher Scientific, Waltham, MA, United States) supplemented with 5% fetal bovine serum (Biowest, Bradenton, FL, United States), 1% penicillin-streptomycin (Invitrogen, Thermo Fisher Scientific, Waltham, MA, United States) and 1&#x2009;&#x03BC;M 2-mercaptoethanol (Sigma-Aldrich, Saint-Louis, MO, United States), at 37&#x00B0;C and 5% CO<sub>2</sub>. hRSV genome persistence has been continuously evaluated by conventional and quantitative RT-PCR (RT-qPCR) to determine expression of viral nucleoprotein (N) mRNA and through direct immunofluorescence to detect expression of nucleocapsid (N) and fusion (F) proteins (<xref ref-type="bibr" rid="ref68">Ruiz-G&#x00F3;mez et al., 2021</xref>). The original P388D1 non-infected macrophages (niM&#x03D5;) were grown under similar conditions as piM&#x03D5; and used as the control group. This study was performed with piM&#x03D5; from passages 161&#x2013;169 and niM&#x03D5; from passages 97&#x2013;103.</p>
</sec>
<sec id="sec4">
<label>2.2</label>
<title>Recombinant <italic>Taenia solium</italic> calreticulin</title>
<p>The full-coding region of the mature rTsCRT without the signal peptide was cloned, expressed and the resulting protein was purified as previously described with some modifications (<xref ref-type="bibr" rid="ref18">Fonseca-Coronado et al., 2011</xref>). Bacteria (BL21) expressing rTsCRT were sonicated (50&#x2009;W) 3 times in 20&#x2009;mM Tris-HCl buffer pH 7.3, in presence of protease inhibitors (Complete, Roche, Indianapolis, IN, United States), DNase (30&#x2009;&#x03BC;g) (Roche, Indianapolis, IN, United States) and RNase (1,300&#x2009;U) (Sigma-Aldrich, Saint-Louis, MO, United States), and centrifugated at 13,000&#x2009;&#x00D7;&#x2009;g for 10&#x2009;min at 4&#x00B0;C. The recombinant protein (53&#x2009;kDa) was purified by separation in 1.5&#x2009;mm thick 10% gels (Tris-glycine) SDS-PAGE, followed by ZnSO<sub>4</sub> 0.2&#x2009;N-Imidazole 0.2&#x2009;M&#x2009;+&#x2009;SDS 0.1% staining (Sigma-Aldrich, Saint-Louis, MO, United States). The enriched recombinant protein was excised from the gel and eluted at 5&#x2009;mV/tube during 8&#x2009;h using an electro-elutor model and electro-dialysed (422 Bio-Rad, Hercules, CA, United States). Endotoxins were measured using the Pierce Endotoxin Kit (Thermo Fisher Scientific, Waltham, MA, United States) following the manufacturer&#x2019;s instructions. Protein quality was examined by SDS-PAGE and protein concentration was determined by the Lowry method. Purified rTsCRT was filtered using a 0.22&#x2009;&#x03BC;M filter and kept at &#x2212;70&#x00B0;C until use.</p>
</sec>
<sec id="sec5">
<label>2.3</label>
<title>MTT assay</title>
<p>piM&#x03D5; and niM&#x03D5; were seeded in 96-well plates (Corning, Corning, NY, United States) (2&#x2009;&#x00D7;&#x2009;10<sup>4</sup>/well) and incubated overnight. Cells were rinsed with PBS and 0.22&#x2009;&#x03BC;m-filtered rTsCRT was added at concentrations of 1, 2, 5 and 10&#x2009;&#x03BC;g/mL in 200&#x2009;&#x03BC;L of supplemented RPMI-1640. rTsCRT was maintained for 24 and 48&#x2009;h and 20&#x2009;&#x03BC;L of 3-[4,5-dimethylthiazole-2-yl]-2,5-diphenyltetrazolium bromide (MTT) solution (Biological Industries, Sartorius, Kibbutz Beit-Haemek, Israel) (5&#x2009;mg/mL in PBS) were added. Following a 3&#x2009;h incubation at 37&#x00B0;C, supernatants were discarded, and formazan crystals dissolved in 100&#x2009;&#x03BC;L of DMSO (Merck, Rahway, NJ, United States) for 15&#x2009;min. Absorbance was measured at 570&#x2009;nm in a microplate reader (Biorad, Hercules, CA, United States). Percentage of cell metabolic activity was estimated by normalizing the optical density (OD) value of rTsCRT treated cells to the OD value of untreated cells &#x00D7;100.</p>
</sec>
<sec id="sec6">
<label>2.4</label>
<title>rTsCRT treatment</title>
<p>niM&#x03D5; and piM&#x03D5; were seeded in 12-well plates (Corning, Corning, NY, United States) (0.5&#x2009;&#x00D7;&#x2009;10<sup>6</sup>/well) and allowed to adhere overnight. The following day, cells were rinsed once with PBS and rTsCRT was added at a final concentration of 5&#x2009;&#x03BC;g/mL in supplemented RPMI-1640. After 6, 24 and 48&#x2009;h, supernatants were collected, centrifuged at 250&#x2009;g for 5&#x2009;min and transferred to a fresh tube. All supernatants were frozen at &#x2212;80&#x00B0;C until use. Additionally, monolayers were treated with 500&#x2009;&#x03BC;L of Trizol reagent (Invitrogen, Thermo Fisher Scientific, Waltham, MA, United States) for RNA extraction.</p>
</sec>
<sec id="sec7">
<label>2.5</label>
<title>RNA extraction and gene expression analysis by RT-qPCR</title>
<p>Total RNA was obtained with the Trizol reagent according to the manufacturer&#x2019;s instructions. Total RNA from non-treated piM&#x03D5; and niM&#x03D5; and treated with 5&#x2009;&#x03BC;g/mL of rTsCRT for 6, 24 and 48&#x2009;h were isolated. RNA concentration for each condition was adjusted to 100&#x2009;ng/&#x03BC;L in RNase-free water. RNA quality was determined by the capillary electrophoresis system Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, United States). Samples showed RIN values between 8.0&#x2013;10.0 and were processed in triplicates in the Microarray Core Facility at the National Institute of Genomic Medicine (INMEGEN) to produce cDNA. The resulting cDNA was hybridized to GeneChip mouse Clariom S microarrays (Thermo Fisher, Waltham, MA, United States), which analyze gene-level expression of &#x003E;20,000 well-annotated mouse genes.</p>
<p>Gene expression was evaluated by one step quantitative RT-qPCR using the Luna Universal Probe One-Step RT-qPCR Kit (NEB, M3005S) (New England Biolabs, Ipswich, MA, United States). Taqman gene expression assays were performed using commercially available primers and probes (Applied Biosystems, Austin, TX, United States) for Il10 (Mm00439614_m1), Il1b (Mm01336189_m1), Il6 (Mm00439653_m1), Tnf-&#x03B1; (Mm00443258_m1) Irg-1 (Mm01224532_m1), Il18 (Mm00434226_m1), Lcn2 (Mm01324470_m1), Cxcl2 (Mm00436450_m1), Socs3 (Mm00545913_s1) and CD40 (Mm00441891m1). Reactions consisted of a volume of 10&#x2009;&#x03BC;L containing 2&#x2009;&#x03BC;L RNA, 5&#x2009;&#x03BC;L Luna Universal One-Step Reaction Mix, 0.5&#x2009;&#x03BC;L Luna WarmStartRT Enzyme Mix, 0.5&#x2009;&#x03BC;L each, forward and reverse primers and 1.5&#x2009;&#x03BC;L RNase-free H<sub>2</sub>O; a LightCycler 2.0 (Roche, Indianapolis, IN, United States) was used. The parameters for PCR amplification were 95 &#x030A;C for 10&#x2009;min, followed by 45&#x2009;cycles each consisting of denaturation at 95&#x00B0;C for 10&#x2009;s, annealing at 60&#x00B0;C for 10&#x2009;s and extension at 72&#x00B0;C for 10&#x2009;s. The housekeeping gene Eef2 (Mm 01171435_gH) was used to normalize mRNA expression. Relative RNA quantitation was calculated using the &#x0394;&#x0394;Ct method (<xref ref-type="bibr" rid="ref40">Livak and Schmittgen, 2001</xref>).</p>
</sec>
<sec id="sec8">
<label>2.6</label>
<title>Microarray analysis</title>
<p>Microarray analysis was performed with the Transcriptome Analysis Console 4.0 (TAC) (Affymetrix, Thermo Fisher Scientific, Waltham, MA, United States). Genes with a fold change threshold of &#x00B1;2 or higher and <italic>p</italic>-value &#x2264;0.05 were considered for subsequent analyzes. DAVID (<xref ref-type="bibr" rid="ref27">Huang et al., 2009</xref>) and Enrichr/Enrichr-KG (<xref ref-type="bibr" rid="ref92">Xie et al., 2021</xref>; <xref ref-type="bibr" rid="ref17">Evangelista et al., 2023</xref>) analyzes were performed with default settings (DAVID: Select_Identifier&#x2009;=&#x2009;Official_gene_symbol, Classification Stringency&#x2009;=&#x2009;Medium, Enrichment score threshold (EASE)&#x2009;=&#x2009;1.0 for Functional Annotation clustering and 0.1 for Gene Ontology and Pathway predictions; Enrichr/Enrichr-KG: Top 30, 20 or 10 GO Biological Process 2021, Minimum libraries and links per gene&#x2009;=&#x2009;1, Minimum links per term&#x2009;=&#x2009;1, Subgraph size limit&#x2009;=&#x2009;100). We obtained a list of the top affected biological processes by DAVID and Enrichr-KG, as well as a visualization of connections of enriched genes and processes with Enrichr-KG. All of them were selected according to their <italic>p</italic>-value (<italic>p</italic>&#x2009;&#x2264;&#x2009;0.05) and previous association with inflammation, antiviral response, or metabolism.</p>
</sec>
<sec id="sec9">
<label>2.7</label>
<title>Virus genome copies</title>
<p>Absolute quantification of the hRSV genome was performed with a plasmid DNA standard curve that includes an 85&#x2009;bp region from the viral N gene (hRSV A strain Long, GeneBank accession AY911262.1). Specific primers and probe (FAM/BHQ1) (OligoT4, Irapuato, GT, Mexico) were designed to target such genomic region: forward, 5&#x2032;-AATTTCCTCACTTTTCCAGTGTAG-3&#x2032;; reverse, 5&#x2032;-TGATTCCTCGGTGTACCTCTG-3&#x2032;; probe, 5&#x2032;GCAATGCTGCTGGCCTAGGCATAAT G-3&#x2032;. One-step RT-qPCR reactions were carried out with SuperScript III Platinum One-Step RT-qPCR Kit (Invitrogen, Thermo Fisher, Waltham, MA, United States). A standard curve was constructed with 10-fold serial dilutions from a plasmid DNA stock with 1&#x2009;&#x00D7;&#x2009;10<sup>7</sup> N gene copies (5&#x2009;&#x03BC;L per reaction). Virus genome copies in piM&#x03D5; treated and untreated with rTsCRT were evaluated in triplicate reactions with 25&#x2009;ng of total RNA, in a thermocycler StepOne Real-Time PCR System (Applied Biosystems, Austin, TX, United States). Cycling program was 50&#x00B0;C for 15&#x2009;min, followed by 40&#x2009;cycles of 95&#x00B0;C for 15&#x2009;s and 60&#x00B0;C for 30&#x2009;s. Mean Ct values were plotted versus the log10 of standard concentrations and unknown hRSV genome copies were determined by interpolation from the standard curve (equation: <inline-formula>
<mml:math id="M1">
<mml:mi>y</mml:mi>
<mml:mo>=</mml:mo>
<mml:mo>&#x2212;</mml:mo>
<mml:mn>1.297</mml:mn>
<mml:mo>ln</mml:mo>
<mml:mfenced open="(" close=")">
<mml:mi>x</mml:mi>
</mml:mfenced>
<mml:mo>+</mml:mo>
<mml:mn>42.265</mml:mn>
<mml:mo>;</mml:mo>
<mml:msup>
<mml:mi>R</mml:mi>
<mml:mn>2</mml:mn>
</mml:msup>
<mml:mo>=</mml:mo>
<mml:mn>0.98</mml:mn>
</mml:math>
</inline-formula>).</p>
</sec>
<sec id="sec10">
<label>2.8</label>
<title>Cytokine assay</title>
<p>niM&#x03D5; and piM&#x03D5; growth media were collected at 6, 24 and 48&#x2009;h of incubation with or without treatment with rTsCRT and stored at &#x2212;80&#x00B0;C until use. Macrophage cultures were performed in triplicate. The concentration of TNF-&#x03B1;, IL-6, INF-&#x03B3;, MCP-1, IL-10, and IL-12 was tested by the Cytometric Bead Array Mouse inflammation kit BDTM (BD Biosciences, San Jose, CA, United States) according to the manufacturer&#x2019;s instructions.</p>
</sec>
<sec id="sec11">
<label>2.9</label>
<title>Statistical analysis</title>
<p>Statistical analysis and graphs were performed with GraphPad Prism 9 (GraphPad Software Inc., San Diego, CA, United States). For parametric data, we used a one-way ANOVA to determine significant differences between groups. For comparison between 2 groups, a Student <italic>t</italic>-test for parametric and Mann&#x2013;Whitney test for non-parametric data were used. A <italic>p</italic>&#x2009;&#x2264;&#x2009;0.05 value was considered as a statistically significant threshold in all tests.</p>
</sec>
</sec>
<sec sec-type="results" id="sec12">
<label>3</label>
<title>Results</title>
<sec id="sec13">
<label>3.1</label>
<title>Modified genes during hRSV persistence in murine macrophages</title>
<p>The gene expression profile was evaluated in niM&#x03D5; and piM&#x03D5; at 6 and 24&#x2009;h. For the microarray analysis we first considered the effect of hRSV persistent infection, contrasting differentially expressed genes in piM&#x03D5; versus niM&#x03D5;. The heatmaps in <xref ref-type="fig" rid="fig1">Figure 1</xref> show that piM&#x03D5; and niM&#x03D5; are clearly separated by the differentially regulated genes (<xref ref-type="supplementary-material" rid="SM1">Supplementary material S1</xref>). Virus persistence altered 2,760 genes in piM&#x03D5; cultured for 6&#x2009;h of which 1,534 were upregulated and 1,226 were downregulated (<xref ref-type="fig" rid="fig1">Figures 1A</xref>,<xref ref-type="fig" rid="fig1">B</xref>). At 24&#x2009;h, 2,990 genes were differentially expressed, 1,530 were upregulated and 1,460 were downregulated (<xref ref-type="fig" rid="fig1">Figures 1C</xref>,<xref ref-type="fig" rid="fig1">D</xref>). A total of 2,180 shared genes were identified at 6 and 24&#x2009;h, while genes expressed only at 6&#x2009;h or 24&#x2009;h were 580 and 810, respectively (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). These results are supported by RT-qPCR experiments where we observed a similar trend in the relative expression of several differentially expressed genes (<xref ref-type="fig" rid="fig1">Figure 1F</xref>).</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Time-dependent gene expression in persistent infection of hRSV versus niM&#x03D5;. <bold>(A)</bold> Heatmap representation of differentially expressed genes in piM&#x03D5; versus niM&#x03D5; after 6&#x2009;h of <italic>in vitro</italic> culture. <bold>(B)</bold> Number of altered genes in piM&#x03D5; at 6&#x2009;h of <italic>in vitro</italic> culture. <bold>(C)</bold> Heatmap representation of differentially expressed genes in piM&#x03D5; versus niM&#x03D5; after 24&#x2009;h of <italic>in vitro</italic> culture. <bold>(D)</bold> Number of altered genes in piM&#x03D5; at 24&#x2009;h of <italic>in vitro</italic> culture. <bold>(E)</bold> Venn diagram of genes expressed only at 6 or 24&#x2009;h and at both timepoints. Top-up-regulated genes are shown in red, while top-down-regulated genes are shown in blue. Common genes expressed at both timepoints are shown in black. <bold>(F)</bold> Microarray expression data validation by qRT-PCR at 6 and 24&#x2009;h. <inline-formula>
<mml:math id="M2">
<mml:mi mathvariant="italic">piM&#x03D5;</mml:mi>
</mml:math>
</inline-formula>, persistently infected macrophages with hRSV; <inline-formula>
<mml:math id="M3">
<mml:mi mathvariant="italic">niM&#x03D5;</mml:mi>
<mml:mtext>,</mml:mtext>
</mml:math>
</inline-formula>&#x2009;non-infected macrophages; hRSV, human respiratory syncytial virus. <italic>p</italic>-values were calculated using the Student <italic>t</italic>-test between microarrays and rt-PCR data for each cytokine: &#x002A;&#x002A;&#x002A;&#x2009;=&#x2009;&#x2264;0.001 and &#x002A;&#x002A;&#x002A;&#x002A;&#x2009;=&#x2009;&#x2264;0.0001.</p>
</caption>
<graphic xlink:href="fmicb-15-1402589-g001.tif"/>
</fig>
<p>Functional annotation analysis showed that the main processes altered at 6 and 24&#x2009;h were related to the inflammatory response, regulation of cytokines and chemokines, defense response to virus, positive regulation of transcription factor activity, and biosynthesis of products such as NO, cholesterol and glycerophospholipids (<xref ref-type="fig" rid="fig2">Figures 2A</xref>,<xref ref-type="fig" rid="fig2">B</xref>). Other modified processes were cell cycle, proliferation, and apoptosis (<xref ref-type="supplementary-material" rid="SM1">Supplementary material S2</xref>).</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>Bioinformatic analysis of niM&#x03D5; and piM&#x03D5;. <bold>(A)</bold> Heatmap of top biological processes altered after the infection with hRSV at 6 and 24&#x2009;h. <bold>(B)</bold> Predicted network of relevant biological processes deregulated at both timepoints. Genes deregulated by hRSV infection (green) and predicted altered processes (pink) using DAVID and Enrichr/Enrichr-KG software. Blank cells represent the absence of the corresponding process at the specified time. hRSV, human respiratory syncytial virus. The values plotted in the heatmap correspond to the <italic>p</italic>-values of each process.</p>
</caption>
<graphic xlink:href="fmicb-15-1402589-g002.tif"/>
</fig>
<p>Defense response or antiviral genes of interest exclusively overexpressed at 6&#x2009;h were <italic>Rsad2</italic>, <italic>Oasl2</italic>, <italic>Isg15</italic> and <italic>Ifih1/Mda5</italic>, whereas IFN-&#x03B1; and IFN-&#x03B2; receptor subunit 1 (<italic>Ifnar1</italic>), as well as genes that mediate inhibition of the inflammatory response, like <italic>Irg1</italic> and <italic>Il10rb</italic> were downregulated (<xref ref-type="supplementary-material" rid="SM1">Supplementary material S1</xref>). The Il1 receptor antagonist (<italic>Il1rn</italic>) mRNA was only induced at 6&#x2009;h, suggesting this gene might have an early role in modulating the inflammatory response in piM&#x03D5;. Interesting genes exclusively overexpressed at 24&#x2009;h were <italic>Il12a</italic>, <italic>Cebpb</italic> and CD40.</p>
<p>Common downregulated genes at 6 and 24&#x2009;h (<xref ref-type="supplementary-material" rid="SM1">Supplementary material S1</xref>) were also associated with the antiviral response and immunomodulation in piM&#x03D5;, like <italic>Ifnar2</italic>, <italic>Ddx58/Rig1</italic>, <italic>Oas2</italic>, <italic>Oas3</italic>, <italic>Mx1</italic>, <italic>Mx2</italic>, <italic>Isg20</italic>, <italic>Ifitm6</italic>, <italic>Parp9</italic> and <italic>Ebi3</italic>. Despite the upregulation of the IFN-stimulated genes <italic>Ifit2</italic> and <italic>Rnase2a</italic>, they were concurrently expressed with the Jak/STAT pathway inhibitor, suppressor of cytokine signaling 2 (<italic>SOCS2</italic>). On the other hand, genes encoding RNA editing enzymes or their subunits such as <italic>Apobec1</italic>, <italic>A1CF</italic> and <italic>Adat1</italic> were downregulated at both time points, whereas the gene encoding the adenosine deaminase acting on RNA (<italic>Adar</italic>) was upregulated only at 24&#x2009;h.</p>
<p>An additional group of genes steadily upregulated at 6 and 24&#x2009;h were those involved in inflammatory activity, such as, <italic>Cxcl2</italic>, <italic>Lcn2</italic>, <italic>Ccl4</italic>, <italic>Ccl6</italic>, <italic>Ccl12</italic>, <italic>Tlr3</italic>, <italic>Tlr2</italic>, <italic>Tlr8</italic>, <italic>Cxcr4</italic>, <italic>Tnfaip6 and Cd9</italic>, while the negative modulator of inflammation <italic>Ctla2a</italic> increased up to 20.3-fold. Upregulated mRNA expressing cytokine genes at 6 and 24&#x2009;h were <italic>Il1a</italic>, <italic>Il1b</italic> and <italic>Il6</italic>, while <italic>Il18</italic> and <italic>Tnf-&#x03B1;</italic> were downregulated. We also identified overexpressed genes involved in resistance to oxidative stress, like <italic>Arg1</italic>, <italic>Oxr1</italic> and <italic>Nostrin</italic> with up to 1784.2-, 6.9-and 2.8-fold-change, respectively.</p>
<p>Genes related to lipid metabolism were also highly modified in piM&#x03D5;. The highest upregulated gene was the scavenger receptor B CD36, with a fold-change value of 7,059 and 4,312 at 6 and 24&#x2009;h, respectively. Other genes involved in lipid metabolism that were significantly upregulated included cathepsins (<italic>Cts</italic>), <italic>Ctsk</italic>, <italic>Ctsh</italic>, and <italic>Ctsl</italic> with fold changes of 2,757-2,171, 218-160, and 53-47, respectively. Lipocalin 2 (<italic>Lcn2</italic>) and peroxisome proliferator activated receptor-&#x03B3; (<italic>Ppar&#x03B3;</italic>) (58&#x2013;218 and 29&#x2013;93, respectively) were also induced.</p>
</sec>
<sec id="sec14">
<label>3.2</label>
<title>rTsCRT is non-cytotoxic for piM&#x03D5; versus niM&#x03D5;</title>
<p>We assessed whether rTsCRT causes cytotoxicity in niM&#x03D5; and piM&#x03D5; treated with concentrations of 1, 2, 5, and 10&#x2009;&#x03BC;g/mL for 24 and 48&#x2009;h. The metabolic activity was evaluated by the MTT assay. Alterations in cellular metabolism may change the ability of the NADPH-dependent cellular oxidoreductase enzymes to reduce MTT to formazan. Consequently, the OD measured in this assay indirectly reflects cellular metabolic activity, and a decrease in OD may be indicative of cytotoxicity. Results showed that 1, 2, and 5&#x2009;&#x03BC;g/mL of rTsCRT did not reduce the metabolic activity in niM&#x03D5; and piM&#x03D5; at 24 or 48&#x2009;h. In fact, both cell lines significantly increased metabolic activity (up to 27%) after treatment with 1&#x2009;&#x03BC;g/mL after 48&#x2009;h. Only 10&#x2009;&#x03BC;g/mL of rTsCRT caused a modest, non-significant cytotoxic effect (~5%). Therefore, 1&#x2013;5&#x2009;&#x03BC;g/mL are suitable non-cytotoxic concentrations to stimulate piM&#x03D5; and niM&#x03D5; (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S1</xref>).</p>
</sec>
<sec id="sec15">
<label>3.3</label>
<title>Modified genes upon rTsCRT treatment</title>
<p>The effect of 5&#x2009;&#x03BC;g/mL of rTsCRT on gene transcription in niM&#x03D5; and piM&#x03D5; was analyzed after 6 and 24&#x2009;h. Differentially expressed genes in each condition were determined by comparison with their respective untreated counterparts. niM&#x03D5; showed 52 altered genes after 6&#x2009;h of treatment of which 31 were upregulated (59.6%), while at 24&#x2009;h the altered genes were 35, including 29 upregulated genes (82.8%) (<xref ref-type="fig" rid="fig3">Figures 3A</xref>&#x2013;<xref ref-type="fig" rid="fig3">D</xref>; <xref ref-type="supplementary-material" rid="SM1">Supplementary material S3</xref>). Eight genes (10.1%) were shared between 6 and 24&#x2009;h belonging to immunoregulatory and proinflammatory responses (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). We validated the microarray expression data by RT-qPCR of some modified immune response genes (<xref ref-type="fig" rid="fig3">Figure 3F</xref>). Interestingly, rTsCRT induced a predominantly transitory inflammatory state in niM&#x03D5;, as genes like <italic>Cxcl2</italic>, <italic>Il1b</italic>, and <italic>Irg1</italic>, that were upregulated at 6&#x2009;h reduced their expression by 42&#x2013;57% at 24&#x2009;h. <italic>Cxcl3</italic>, <italic>Ccl4</italic>, <italic>Nos2</italic>, <italic>Irak3</italic>, <italic>Nfkbia</italic>, <italic>Nfkbid</italic> and <italic>Nfkbiz</italic>, showed a 2&#x2013;4-fold increase at 6&#x2009;h and returned to basal levels at 24&#x2009;h. Only the inflammatory genes <italic>Il1a</italic> and <italic>Lcn2</italic>, as well as the immunoregulatory gene <italic>Clec4a</italic> were expressed at higher levels at 24&#x2009;h (<xref ref-type="fig" rid="fig3">Figure 3G</xref>).</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p>Time-dependent gene expression in niM&#x03D5; treated with 5&#x2009;&#x03BC;g of recombinant <italic>T. solium</italic> calreticulin (rTsCRT<sup>+</sup>). <bold>(A)</bold> Heatmap representation of differentially expressed genes in niM&#x03D5; after rTsCRT treatment for 6&#x2009;h. <bold>(B)</bold> Number of altered genes in niM&#x03D5; after rTsCRT treatment for 6&#x2009;h. <bold>(C)</bold> Heatmap representation of differentially expressed genes in niM&#x03D5; after rTsCRT treatment for 24&#x2009;h. <bold>(D)</bold> Number of altered genes in niM&#x03D5; after rTsCRT treatment for 24&#x2009;h. <bold>(E)</bold> Venn diagram of the genes expressed only at 6 or 24&#x2009;h and at both timepoints. Top-up-regulated genes are shown in red, while top-down-regulated genes are shown in blue. Common genes expressed at both timepoints are shown in black. <bold>(F)</bold> Microarray expression data validation by qRT-PCR at 6 and 24&#x2009;h. <bold>(G)</bold> Temporary gene expression of <inline-formula>
<mml:math id="M4">
<mml:mi mathvariant="italic">niM&#x03D5;</mml:mi>
</mml:math>
</inline-formula> treated with rTsCRT. <inline-formula>
<mml:math id="M5">
<mml:mi mathvariant="italic">niM&#x03D5;</mml:mi>
</mml:math>
</inline-formula>, non-infected macrophages. <italic>p</italic>-values were calculated using the Student <italic>t</italic>-test between microarrays and rt-PCR data for each cytokine: &#x002A;&#x2009;=&#x2009;&#x003C;0.05, &#x002A;&#x002A;&#x2009;=&#x2009;&#x003C;0.01, and &#x002A;&#x002A;&#x002A;&#x2009;=&#x2009;&#x2264;0.001.</p>
</caption>
<graphic xlink:href="fmicb-15-1402589-g003.tif"/>
</fig>
<p>In piM&#x03D5; we identified 38 altered genes at 6 and 24&#x2009;h of treatment with rTsCRT, including 27 and 34 upregulated genes, respectively (<xref ref-type="fig" rid="fig4">Figures 4A</xref>&#x2013;<xref ref-type="fig" rid="fig4">D</xref>; <xref ref-type="supplementary-material" rid="SM1">Supplementary material S4</xref>). Ten genes were shared (17.3%) between 6 and 24&#x2009;h including <italic>Zc3h12a</italic> and those associated with proinflammatory responses such as <italic>Nos2</italic>, <italic>Il1b</italic>, <italic>Irak3</italic>, <italic>Csf2</italic>, <italic>Csf3</italic>, <italic>Il6</italic>, <italic>Tnf-&#x03B1;</italic>, <italic>Cxcl2</italic> and <italic>Cd40</italic> (<xref ref-type="fig" rid="fig4">Figures 4E</xref>,<xref ref-type="fig" rid="fig4">F</xref>; <xref ref-type="supplementary-material" rid="SM1">Supplementary material S4</xref>). <italic>Socs3</italic>, the inhibitor of STAT3 was expressed only at 6&#x2009;h, while inflammatory genes such as <italic>Lcn2</italic>, <italic>Ppbp</italic> and <italic>Mmp3</italic>, as well as the immunoregulatory <italic>Clec4a</italic> and <italic>Il10ra</italic> were only upregulated at 24&#x2009;h. These observations suggest that rTsCRT contributed to maintain an inflammatory phenotype in piM&#x03D5; (<xref ref-type="fig" rid="fig4">Figure 4G</xref>; <xref ref-type="supplementary-material" rid="SM1">Supplementary materials S3, S4</xref>).</p>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption>
<p>Time-dependent gene expression in piM&#x03D5; treated with 5&#x2009;&#x03BC;g of recombinant <italic>T. solium</italic> calreticulin (rTsCRT<sup>+</sup>). <bold>(A)</bold> Heatmap representation of differentially expressed genes in piM&#x03D5; after rTsCRT treatment for 6&#x2009;h. <bold>(B)</bold> Number of altered genes in piM&#x03D5; after rTsCRT treatment for 6&#x2009;h. <bold>(C)</bold> Heatmap representation of differentially expressed genes in piM&#x03D5; after rTsCRT treatment for 24&#x2009;h. <bold>(D)</bold> Number of altered genes in piM&#x03D5; after rTsCRT treatment for 24&#x2009;h. <bold>(E)</bold> Venn diagram of the genes expressed only at 6 or 24&#x2009;h and at both timepoints. Top up-regulated genes are shown in red, while top down-regulated genes are in shown blue. Common genes expressed at both times are in black. <bold>(F)</bold> Microarray expression data validation by qRT-PCR at 6 and 24&#x2009;h <bold>(G)</bold> Temporary gene expression of <inline-formula>
<mml:math id="M6">
<mml:mi mathvariant="italic">piM&#x03D5;</mml:mi>
</mml:math>
</inline-formula> treated with rTsCRT. <inline-formula>
<mml:math id="M7">
<mml:mi mathvariant="italic">piM&#x03D5;</mml:mi>
</mml:math>
</inline-formula>, persistently infected macrophages with hRSV; hRSV, human respiratory syncytial virus. <italic>p</italic>-values were calculated using the Student <italic>t</italic>-test between microarrays and rt-PCR data from each cytokine: &#x002A;&#x2009;=&#x2009;&#x003C;0.05, &#x002A;&#x002A;&#x2009;=&#x2009;&#x003C;0.01, and &#x002A;&#x002A;&#x002A;&#x2009;=&#x2009;&#x2264;0.001.</p>
</caption>
<graphic xlink:href="fmicb-15-1402589-g004.tif"/>
</fig>
<p>To evaluate this premise, we treated piM&#x03D5; with rTsCRT for 48&#x2009;h to assess the maintenance of the proinflammatory state. We observed the downregulation of 26 genes (<xref ref-type="supplementary-material" rid="SM2">Supplementary Figure S2</xref>), of which <italic>Il6</italic>, <italic>Tnf-&#x03B1;</italic>, <italic>Cxcl2</italic>, <italic>Cd40</italic>, <italic>Nos2</italic>, <italic>Zc3h12a</italic>, <italic>Irak3</italic>, <italic>Csf2</italic> and <italic>Csf3</italic> &#x201C;returned to basal levels, whereas <italic>Il1b</italic>, <italic>Il1a</italic>, <italic>Ppbp</italic>, and <italic>Lcn2</italic> displayed a 2&#x2013;3.7-fold increase as compared to their expression at 24&#x2009;h. Furthermore, rTsCRT induced expression of <italic>Pparg</italic>, <italic>Igsf6</italic>, <italic>Tlr8</italic>, <italic>Wfdc17</italic>, <italic>Sod</italic> and <italic>Nfkbia</italic> mRNA exclusively at 48&#x2009;h (<xref ref-type="fig" rid="fig4">Figure 4G</xref>; <xref ref-type="supplementary-material" rid="SM1">Supplementary material S4</xref>).</p>
<p>The main processes affected in niM&#x03D5; and piM&#x03D5; by treatment with rTsCRT were related to the inflammatory response, as well as the cellular response to cytokine stimulus (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Processes such as the cellular response to lipids, cellular response to oxygen-containing compounds and regulation of NO biosynthesis were only activated in niM&#x03D5; (<xref ref-type="fig" rid="fig5">Figures 5A</xref>&#x2013;<xref ref-type="fig" rid="fig5">C</xref>; <xref ref-type="supplementary-material" rid="SM1">Supplementary materials S5, S6</xref>). In contrast, processes related to positive regulation of cytokine production, regulation of IL-6 production, positive regulation of transcription factors like STAT and NF-kB, regulation of neutrophil activity coupled to IL-2 production and the positive regulation of ERK1/ERK2 cascade were only induced in piM&#x03D5; (<xref ref-type="fig" rid="fig5">Figures 5A</xref>&#x2013;<xref ref-type="fig" rid="fig5">F</xref>; <xref ref-type="supplementary-material" rid="SM1">Supplementary material S6</xref>).</p>
<fig position="float" id="fig5">
<label>Figure 5</label>
<caption>
<p>Bioinformatic analysis of rTsCRT-treated (rTsCRT<sup>+</sup>) versus non-treated (rTsCRT<sup>&#x2212;</sup>) macrophages. <bold>(A)</bold> Heatmap of biological processes altered after the treatment of niM<inline-formula>
<mml:math id="M8">
<mml:mi>&#x03D5;</mml:mi>
</mml:math>
</inline-formula> and <inline-formula>
<mml:math id="M9">
<mml:mi mathvariant="italic">piM&#x03D5;</mml:mi>
</mml:math>
</inline-formula> with rTsCRT at 6, 24, or 48&#x2009;h. <bold>(B,C)</bold> Predicted network in <inline-formula>
<mml:math id="M10">
<mml:mi mathvariant="italic">niM&#x03D5;</mml:mi>
</mml:math>
</inline-formula> at 6&#x2009;h and 24&#x2009;h. <bold>(D,E)</bold> Predicted network in <inline-formula>
<mml:math id="M11">
<mml:mi mathvariant="italic">piM&#x03D5;</mml:mi>
</mml:math>
</inline-formula> at 6&#x2009;h and 24&#x2009;h. <bold>(F)</bold> Predicted network in <inline-formula>
<mml:math id="M12">
<mml:mi mathvariant="italic">piM&#x03D5;</mml:mi>
</mml:math>
</inline-formula> at 48&#x2009;h. Genes deregulated by hRSV infection (green) and the predicted altered processes (pink) using DAVID and Enrichr/Enrichr-KG software. Blank cells represent the absence of the corresponding process at the specified timepont. hRSV, human respiratory syncytial virus; rTsCRT, recombinant <italic>T. solium</italic> calreticulin;&#x2009;<inline-formula>
<mml:math id="M13">
<mml:mi mathvariant="italic">niM&#x03D5;</mml:mi>
<mml:mtext>,</mml:mtext>
</mml:math>
</inline-formula><inline-formula>
<mml:math id="M14">
<mml:mi mathvariant="italic">niM&#x03D5;</mml:mi>
<mml:mtext>,</mml:mtext>
</mml:math>
</inline-formula>&#x2009;non-infected macrophages;&#x2009;<inline-formula>
<mml:math id="M15">
<mml:mi mathvariant="italic">piM&#x03D5;</mml:mi>
<mml:mtext>,</mml:mtext>
</mml:math>
</inline-formula>&#x2009;persistently infected macrophages. The values plotted in the heatmap correspond to the <italic>p</italic>-values of each process.</p>
</caption>
<graphic xlink:href="fmicb-15-1402589-g005.tif"/>
</fig>
</sec>
<sec id="sec16">
<label>3.4</label>
<title>rTsCRT treatment increases cytokine production and reduces viral load in hRSV in piM&#x03D5;</title>
<p>After observing that the inflammatory and immune responses are the main biological processes affected by rTsCRT, we evaluated the implication of the exacerbated proinflammatory environment induced by rTsCRT treatment on virus replication in piM&#x03D5; treated for 6, 24 and 48&#x2009;h. <xref ref-type="fig" rid="fig6">Figure 6A</xref> shows that rTsCRT treatment significantly reduced the number of hRSV genome copies at 24 and 48&#x2009;h in 36 and 42%, respectively, in comparison to non-treated piM&#x03D5;. Comparison between piM&#x03D5; treated for 24&#x2009;h and 48&#x2009;h displayed a significant progressive reduction in virus genome replication of 53%, suggesting that rTsCRT might control hRSV replication through activation/exacerbation of the inflammatory immune response. Accordingly, we observed a statistically significant higher production of TNF-&#x03B1; in niM&#x03D5; and piM&#x03D5; treated with rTsCRT for 6, 24 and 48&#x2009;h as compared to non-treated controls (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). Additionally higher levels of IL-6 were found in treated piM&#x03D5; at 48&#x2009;h (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). We found no differences in the levels of IFN-&#x03B3;, MCP-1, IL-10 and IL12-p70 in piM&#x03D5; as compared to niM&#x03D5; (data not shown).</p>
<fig position="float" id="fig6">
<label>Figure 6</label>
<caption>
<p>Viral replication and cytokine levels after rTsCRT treatment. <bold>(A)</bold> hRSV gene copies at 6, 24 and 48&#x2009;h. <bold>(B)</bold> TNF-&#x03B1; and <bold>(C)</bold> IL-6 levels in <inline-formula>
<mml:math id="M16">
<mml:mi mathvariant="italic">niM&#x03D5;</mml:mi>
</mml:math>
</inline-formula>and <inline-formula>
<mml:math id="M17">
<mml:mi mathvariant="italic">piM&#x03D5;</mml:mi>
</mml:math>
</inline-formula> at 6, 24 and 48&#x2009;h after culture. hRSV, human respiratory syncytial virus; rTsCRT, recombinant <italic>T. solium</italic> calreticulin; <inline-formula>
<mml:math id="M18">
<mml:mi mathvariant="italic">niM&#x03D5;</mml:mi>
<mml:mtext>,</mml:mtext>
</mml:math>
</inline-formula>&#x2009;non-infected macrophages; <inline-formula>
<mml:math id="M19">
<mml:mi mathvariant="italic">piM&#x03D5;</mml:mi>
<mml:mtext>,</mml:mtext>
</mml:math>
</inline-formula>&#x2009;persistently infected macrophages. <italic>p</italic>-values were calculated using the Student <italic>t</italic>-test between treated and untreated <inline-formula>
<mml:math id="M20">
<mml:mi mathvariant="italic">piM&#x03D5;</mml:mi>
</mml:math>
</inline-formula> for RSV gene copies and the Mann&#x2013;Whitney test was used for cytokine concentrations between <inline-formula>
<mml:math id="M21">
<mml:mi mathvariant="italic">niM&#x03D5;</mml:mi>
</mml:math>
</inline-formula> and <inline-formula>
<mml:math id="M22">
<mml:mi mathvariant="italic">piM&#x03D5;</mml:mi>
<mml:mtext>,</mml:mtext>
</mml:math>
</inline-formula> &#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05 and &#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.01.</p>
</caption>
<graphic xlink:href="fmicb-15-1402589-g006.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="sec17">
<label>4</label>
<title>Discussion</title>
<p>In this study we investigated the transcriptional signature of piM&#x03D5; and found that persistent hRSV infection turns on predominantly genes involved in inflammation, antiviral response, as well as arginine and lipid metabolism, suggesting that piM&#x03D5; attain a mixed M1/M2 profile. Additionally, we analyzed the transcriptional changes induced by rTsCRT treatment and showed further stimulation of the inflammatory response. This stimulation was associated with a reduction in the number of hRSV copies in piM&#x03D5;.</p>
<p>In addition to epithelial cells, hRSV can infect both human and mouse alveolar macrophages (AM&#x03D5;) (<xref ref-type="bibr" rid="ref13">de Souza et al., 2019</xref>; <xref ref-type="bibr" rid="ref31">Johnson et al., 2007</xref>; <xref ref-type="bibr" rid="ref42">Makris et al., 2016</xref>; <xref ref-type="bibr" rid="ref61">Ravi et al., 2013</xref>). Evidence suggests that macrophage infection is temporarily productive as infective viruses are detected at very low titers (&#x2264;2&#x2009;&#x00D7;&#x2009;10<sup>1</sup> PFU/mL). Subsequently, it changes to a nonproductive state (absence of virions) with persistent expression of viral proteins, while recovery of viral RNA is sustained (<xref ref-type="bibr" rid="ref76">Sarmiento et al., 2002</xref>; <xref ref-type="bibr" rid="ref61">Ravi et al., 2013</xref>). The low-to-nonproductive hRSV infection in macrophages might not be important to propagate the virus. Nevertheless, viral proteins and nucleic acids persist as chronic stimuli for the immune system (<xref ref-type="bibr" rid="ref63">Rivera-Toledo et al., 2017</xref>; <xref ref-type="bibr" rid="ref13">de Souza et al., 2019</xref>; <xref ref-type="bibr" rid="ref61">Ravi et al., 2013</xref>).</p>
<p>During acute hRSV infection viral dsRNA is detected by RIG-I and MDA5 to activate IRF3, which translocates to the nucleus and promotes transcription of IFN-&#x03B2;. IFN-&#x03B2; interacts in both autocrine and paracrine manners through the heterodimeric receptor composed of the IFNAR1 and IFNAR2 subunits to activate the Jak/STAT signaling pathway. Ultimately, the heterotrimeric interferon-stimulated gene factor 3 (ISGF3), composed of STAT-1, STAT-2 and IRF9 is assembled and translocates to the nucleus to initiate the transcription of multiple interferon-stimulated genes (<xref ref-type="bibr" rid="ref12">David et al., 1993</xref>). Interestingly, in this study we observed that piM&#x03D5; downregulated genes involved in the recognition of viral RNA and genes transcribed in response to IFN-I, such as <italic>Ddx58/Rig1</italic>, <italic>Ifnar1</italic>, <italic>Ifnar2</italic>, <italic>Stat1</italic>, <italic>Stat2</italic> and <italic>Irf9</italic>. Conversely, the expression levels of <italic>Ifna</italic> and <italic>Ifnb</italic> remained unaltered. Previously, we reported that IRF3 is active in piM&#x03D5;, as it is normally phosphorylated and located in the nucleus. However, piM&#x03D5; do not respond to either endogenous or exogenous IFN-&#x03B2;, as demonstrated by the lack of STAT-1 phosphorylation after a 45&#x2009;min stimulation, thus limiting the expression of antiviral genes (<xref ref-type="bibr" rid="ref64">Rivera-Toledo et al., 2015</xref>). A main function of the hRSV nonstructural proteins 1 and 2 (NS1 and NS1) is to evade the IFN-I-mediated antiviral response by targeting RIG-I, MAVS and STAT-2, as well as to induce expression of suppressor of cytokines signaling 1&#x2013;3 (SOCS 1&#x2013;3) that blocks the activation of the Jak/STAT pathway (<xref ref-type="bibr" rid="ref25">Hashimoto et al., 2009</xref>; <xref ref-type="bibr" rid="ref80">Sedeyn et al., 2019</xref>). It was recently described that NS1directly binds to regulatory elements of immune response genes during hRSV infection, suppressing their transcription (<xref ref-type="bibr" rid="ref55">Pei et al., 2021</xref>). The antiviral transcriptomic profile reported herein agrees with these data. We observed either downregulation or transitory expression of many antiviral genes. However, genes such as <italic>Ifitm10</italic>, <italic>Ifi203</italic>, <italic>Ifi205</italic>, <italic>Ifit1</italic> and <italic>Ifit2</italic> showed an upregulated transcription at 6 and 24&#x2009;h, suggesting that expression of some antiviral genes is regulated by alternative pathways to ensure host-cell survival during viral infections. Further underscoring the importance of antiviral pathways in controlling hRSV replication. The balance of an active immune system, capable of limiting virus replication, and the ability of the virus to dampen such antiviral responses are essential conditions to prevent cell death and facilitate long-term viral infections (<xref ref-type="bibr" rid="ref24">Griffin, 2022</xref>).</p>
<p>In addition to IRF3, NF-kB can be activated by ligands of TLR3 in a MyD88-independent manner and by signaling via the IL-1/IL-1-Receptor through adaptor proteins expressed by <italic>Myd88</italic>, <italic>Tollip</italic> and <italic>Peli1</italic>. The latter two genes, along with <italic>Tlr3</italic> were upregulated in piM&#x03D5;. Hence, IRF3 and NF-kB may be key transcription factors controlling the long-term interaction between the virus and host cells. IRF3 does not exclusively target type-I interferon genes, it also induces the transcription of other antiviral genes, as well as the chemokine <italic>Ccl5</italic> that has been shown to have antiapoptotic properties in macrophages (<xref ref-type="bibr" rid="ref14">Diamond and Farzan, 2013</xref>; <xref ref-type="bibr" rid="ref23">Grandvaux et al., 2002</xref>; <xref ref-type="bibr" rid="ref29">Jiang et al., 2004</xref>; <xref ref-type="bibr" rid="ref85">Tyner et al., 2005</xref>). Accordingly, while we did not observe alterations in the expression of <italic>Ifn &#x03B1;/&#x03B2;</italic>, the ISGF3-related genes were downregulated in piM&#x03D5;. Overexpression of <italic>Ccl5</italic> and some antiviral genes could be explained by an ISGF3-independent signaling pathway, potentially involving direct activity of IRF3 and/or NF-kB (<xref ref-type="bibr" rid="ref14">Diamond and Farzan, 2013</xref>). In fact, NF-kB activation is induced by diverse stimuli making it an essential transcription factor that mediates responses to physiological stress (<xref ref-type="bibr" rid="ref54">Pahl, 1999</xref>). Promoters of many interferon-stimulated genes (ISGs) have binding sites for NF-&#x03BA;B and cooperate with IRFs to establish the antiviral state (<xref ref-type="bibr" rid="ref1">Antonczyk et al., 2019</xref>).</p>
<p>Other target genes for NF-kB include cytokines, chemokines, effectors of the oxidative stress and apoptosis, immunoreceptors and transcription factors (<xref ref-type="bibr" rid="ref54">Pahl, 1999</xref>; <xref ref-type="bibr" rid="ref51">Nilsson-Payant et al., 2021</xref>). In piM&#x03D5; we identified upregulation of many proinflammatory cytokine and chemokine genes, like <italic>Il1a</italic>, <italic>Il1b</italic>, <italic>Il6</italic>, <italic>Il12a</italic>, <italic>Ccl2</italic>, <italic>Ccl4</italic>, <italic>Ccl7</italic>, <italic>Ccl12</italic>, <italic>Cxcl2</italic>, <italic>Cxcl10</italic> and <italic>Cxcl14</italic>. These proinflammatory cytokines are associated with a M1 phenotype in macrophages. In contrast, <italic>Tnf-&#x03B1;</italic>, <italic>Il18</italic> and <italic>Il18</italic> receptor accessory protein (<italic>Il18rap</italic>) that also have a central function as proinflammatory mediators, were downregulated (<xref ref-type="bibr" rid="ref62">Rex et al., 2020</xref>). One pathway that can induce expression of TNF-&#x03B1;, IL-1&#x03B1;, IL-1&#x03B2; and IL-6 is through IL-18/IL-18 receptor and IL-18rap (<xref ref-type="bibr" rid="ref84">Tsutsui et al., 1997</xref>). We found that the components of the IL-18 signaling pathway were downregulated in piM&#x03D5;. Accordingly, expression of Tnfa is negative regulated in piM&#x03D5;. However, we detected overexpression of <italic>Il1a</italic>, <italic>Il1b</italic> and <italic>Il6</italic>, suggesting that alternative pathways can compensate for the reduced activity of the IL-18 signaling in inducing these cytokines. Additionally, the apoptosis-associated speck-like protein containing a CARD domain (Asc or Pycard) and the caspase 1 genes, both related to processing of the pro-IL1&#x03B2; through the Nlrp3 inflammasome (<xref ref-type="bibr" rid="ref78">Schroder and Tschopp, 2010</xref>) were downregulated, suggesting that Il1&#x03B2; might not be in its bioactive form. Indeed, we have observed very low levels of IL-1&#x03B2; in conditioned medium from piM&#x03D5; (<xref ref-type="bibr" rid="ref63">Rivera-Toledo et al., 2017</xref>).</p>
<p>We compared 3 earlier transcriptional studies conducted in mouse macrophages and A549 epithelial cells acutely infected with hRSV for 20&#x2013;24&#x2009;h with our results in piM&#x03D5; (<xref ref-type="supplementary-material" rid="SM1">Supplementary Table S1</xref>). These studies were mainly focused on genes related to the immune response. We identified equivalent fold-change expression of <italic>Il1a</italic>, <italic>Il1b</italic>, <italic>Il6</italic>, and some antiviral genes in piM&#x03D5; and acute hRSV infection. Interestingly, we observed the downregulation of genes such as <italic>Tnf-&#x03B1;</italic>, <italic>Il18</italic>, <italic>Mx1</italic>, <italic>Rig1</italic>, <italic>Pkr</italic>, <italic>Stat1</italic>, <italic>Stat2</italic> and <italic>Irf9</italic>, which appear to be hallmarks of hRSV persistence in contrast to the acute infection.</p>
<p>During early stages of hRSV infection TNF-&#x03B1; plays a protective role in the control of viral replication, while its chronic production can cause severe illness through immunopathology (<xref ref-type="bibr" rid="ref50">Neuzil et al., 1996</xref>; <xref ref-type="bibr" rid="ref70">Rutigliano and Graham, 2004</xref>). Therefore, TNF-&#x03B1; has a critical role in development and outcome of the hRSV infection and its expression is tightly regulated. The transcriptional regulator BCL3 that belongs to the IkB protein family, modulates <italic>Tnf-&#x03B1;</italic> expression by recruiting histone deacetylases to its promoter and induce a repressive chromatin state (<xref ref-type="bibr" rid="ref88">Walker et al., 2013</xref>). We identified upregulation of Bcl3 gene at 6 and 24&#x2009;h, accompanied by overexpression of the histone deacetylases (Hdac)-2, 8 and 10 in piM&#x03D5;. These observations suggest that these genes may participate in the pathway responsible for downregulating <italic>Tnf-&#x03B1;</italic> transcription. However, these findings require experimental validation.</p>
<p>Concerning proteins related to the transcription factor NF-kB, we identified upregulation of <italic>Nfkb1</italic> (p50), <italic>Nfkbia</italic> (Ikba) and <italic>Nfkbiz</italic> (I&#x03BA;B&#x03B6;). Previous studies have shown that inflammatory stimuli induce the expression of I&#x03BA;B&#x03B6; in monocytes/macrophages (<xref ref-type="bibr" rid="ref81">Sundaram et al., 2016</xref>). I&#x03BA;B&#x03B6; can subsequently associate with p50 homodimers bound to the IL-6 promoter, facilitating its transcription (<xref ref-type="bibr" rid="ref32">Kamata et al., 2010</xref>). These mechanisms may contribute to the upregulation of IL-6 mRNA in piM&#x03D5;. The role of IL-6 during viral infections may be protective, by inhibiting virus replication or deleterious, through a synergistic interaction with IL-17 that induces antiapoptotic molecules avoiding elimination of infected cells and promoting long-term infections (<xref ref-type="bibr" rid="ref87">Velazquez-Salinas et al., 2019</xref>). Although IL-6 has been associated with hRSV severe disease in infants, its participation in virus persistence has not been studied (<xref ref-type="bibr" rid="ref46">McNamara et al., 2004</xref>).</p>
<p>The transcriptional profile in piM&#x03D5; suggests the involvement of multiple mechanisms to maintain hRSV persistence, including inhibition of <italic>Tnf-&#x03B1;</italic> expression and the IFN-I response. The apparent paradoxical upregulation of some antiviral genes, such as the RNA editing enzyme <italic>Adar1</italic>, <italic>Isg20</italic>, and genes within the IFIT and IFITM families (<italic>Ifit1</italic>, <italic>Ifit2</italic>, and <italic>Ifitm10</italic>), which restrict viral entry by altering membrane fusion and virus genome replication, may indicate molecular strategies used by the virus to modulate its own replication and persistence. For instance, ADAR1 induces hypermutation (A-to-G substitutions) in the matrix gene of the measles virus, resulting in its defective expression. This leads to a lack of infectious viral particles and persistence of virus genome in the central nervous system, resulting in fatal subacute sclerosing panencephalitis (<xref ref-type="bibr" rid="ref73">Samuel, 2012</xref>). These findings are consistent with our previous results, which show defective virus production and a lack of syncytia formation in piM&#x03D5;. Additionally, a high proportion of A-to-G transitions is a hallmark of the persistent hRSV genome (GenBank accession no. MT492011 and MT492012) (<xref ref-type="bibr" rid="ref76">Sarmiento et al., 2002</xref>; <xref ref-type="bibr" rid="ref68">Ruiz-G&#x00F3;mez et al., 2021</xref>).</p>
<p>Genes associated with arginine metabolism also showed profound alterations during hRSV persistence. Notably, <italic>Arg1</italic> ranked third among the genes with the highest transcription fold change, in agreement with our earlier findings (<xref ref-type="bibr" rid="ref75">Santiago-Olivares et al., 2019</xref>). In the arginine biosynthetic pathway, nitric oxide synthase 2 (NOS2) produces nitric oxide (NO) and citrulline from L-arginine. Then, argininosuccinate synthase 1 (ASS1) recycles citrulline to produce argininosuccinate, which is the substrate of arginosuccinate lyase (<xref ref-type="bibr" rid="ref60">Rath et al., 2014</xref>). An increased expression of the <italic>Ass1</italic> gene in piM&#x03D5; suggests that arginine metabolism is active to allow bioavailability of this amino acid as a NOS2 substrate, since NO is essential to inhibit viral infection. Nevertheless, overexpression of Arg1 that has higher affinity for arginine compared to that of NOS2, can importantly divert the synthesis of NO contributing to hRSV persistence (<xref ref-type="bibr" rid="ref75">Santiago-Olivares et al., 2019</xref>).</p>
<p>Macrophages with an M2 phenotype are associated with expression of <italic>Arg1</italic> and synthesis of ornithine, proline and polyamines (<xref ref-type="bibr" rid="ref43">Mart&#x00ED; et al., 2021</xref>) that modulate inflammation and in tissue repair (<xref ref-type="bibr" rid="ref36">Kieler et al., 2021</xref>). By overexpressing <italic>Arg1</italic>, hRSV can shift the balance of arginine metabolism to the production of polyamines that may participate in genome packaging and activity of viral enzymes (<xref ref-type="bibr" rid="ref83">Tom&#x00E9;, 2021</xref>), to ensure persistence and concomitantly evade elimination by NO. Indeed, ornithine aminotransferase (OAT) and ornithine decarboxylase (ODC) that produce proline and glutamate and polyamines, respectively (<xref ref-type="bibr" rid="ref8">Caldwell et al., 2015</xref>) are upregulated in piM&#x03D5;.</p>
<p>The anti-inflammatory M2 phenotype is also favored by fatty acid oxidation (FAO) and oxidative phosphorylation (<xref ref-type="bibr" rid="ref2">Batista-Gonzalez et al., 2020</xref>). Our transcriptome analysis showed upregulated expression of neutrophil gelatinase&#x2013;associated lipocalin 2 (<italic>Lcn-2</italic>), peroxisome proliferator activated receptor-&#x03B3; (<italic>Ppar&#x03B3;</italic>), as well as CD36, all of which are involved in FAO (<xref ref-type="bibr" rid="ref10">Chawla, 2010</xref>; <xref ref-type="bibr" rid="ref30">Jin et al., 2011</xref>; <xref ref-type="bibr" rid="ref39">Lim et al., 2006</xref>). Moreover, piM&#x03D5; upregulated the cysteine proteases cathepsins (<italic>Cts</italic>) K, L and B, shown to promote a M2 macrophage phenotype in tumor-associated macrophages (<xref ref-type="bibr" rid="ref38">Li et al., 2019</xref>). M2 polarization is induced by several viruses as an immune evasion mechanism for efficient replication (<xref ref-type="bibr" rid="ref74">Sang et al., 2015</xref>; <xref ref-type="bibr" rid="ref93">Yu et al., 2022</xref>). In alveolar macrophages, hRSV can polarize the initial M1 response to an M2 phenotype that can promote persistent infection and continuous activation of the immune response (<xref ref-type="bibr" rid="ref89">Wang et al., 2022</xref>). Thus, the antiviral and inflammatory responses together with modulation of the arginine and lipid metabolism pathways contribute to viral persistence and host cell survival (<xref ref-type="fig" rid="fig7">Figure 7</xref>).</p>
<fig position="float" id="fig7">
<label>Figure 7</label>
<caption>
<p>Transcriptional signature during hRSV persistence in macrophages and after treatment with rTsCRT. Inflammation, antiviral response, oxidative stress, lipid and arginase metabolisms are biological processes altered during virus persistence. Up- and down-regulation of proinflammatory, antiviral and tolerogenic or immunomodulatory genes suggest a gene expression balance to allow virus-host coexistence, particularly, promoting a mixed M1/M2 phenotype in piM&#x03D5;. Treatment with rTsCRT boosted the proinflammatory/immunomodulatory transcriptome, involving up-regulation of <italic>Il1a</italic>, <italic>Il1b</italic>, <italic>Nos2</italic> and <italic>Tnf-&#x03B1;</italic>, which might mediate the reduction of viral load. rTsCRT, recombinant <italic>T. solium</italic> calreticulin.</p>
</caption>
<graphic xlink:href="fmicb-15-1402589-g007.tif"/>
</fig>
<p>rTsCRT potentiated the proinflammatory state induced by the presence of the replicating hRSV in piM&#x03D5;. <italic>Ila</italic>, <italic>Il1b</italic>, <italic>Lcn2</italic>, <italic>Cxcl2</italic> and <italic>Nos2</italic> expression were stimulated in both niM&#x03D5; and piM&#x03D5;, while <italic>Il6</italic>, <italic>Tnf-&#x03B1;</italic> and <italic>Socs3</italic> were upregulated only in piM&#x03D5;. The proinflammatory effects of rTsCRT treatment were accompanied by the expression of negative modulators such as <italic>Socs3</italic>, leucine rich repeat containing 25 (<italic>Lrrc25</italic>) in piM&#x03D5;, as well as <italic>Zc3h12a</italic>, a RNase that post-transcriptionally regulates <italic>Il6</italic> mRNA, along <italic>Clec4a1</italic>, and <italic>IRAK3</italic> in both niM&#x03D5; and piM&#x03D5;. Expression of zinc finger protein 36, C3H type-like 1 (<italic>Zfp36l1</italic>), critical for the decay of the mRNAs for TNF-&#x03B1;, was induced by rTsCRT treatment after 48&#x2009;h (<xref ref-type="bibr" rid="ref45">Matsushita et al., 2009</xref>). Thus, treatment with rTsCRT induced a proinflammatory phenotype accompanied by intrinsic regulation of the inflammatory response.</p>
<p>Treatment with rTsCRT resulted in a reduction in the viral load in piM&#x03D5;. This effect was accompanied by the induction of proinflammatory cytokine and chemokine genes, as well as by the production of TNF-&#x03B1; and IL-6 in rTsCRT-treated piM&#x03D5;. Accordingly, the transcriptomic analysis showed that rTsCRT reversed the inhibition of <italic>Tnf-&#x03B1;</italic> expression induced by viral persistence and upregulated the expression of <italic>Tnf-&#x03B1;</italic> in rTsCRT-treated piM&#x03D5;. TNF-&#x03B1; has been shown to have antiviral activity for several viruses including hRSV and can stimulate the NF&#x03BA;B and MAPK pathways, as well as genes such as <italic>Il1b</italic>, <italic>Il6</italic>, <italic>Csf2</italic>, <italic>Ptgs2</italic>, <italic>Socs3</italic> and <italic>Nfkbia</italic>, all of which were upregulated in rTsCRT-treated piM&#x03D5; (<xref ref-type="fig" rid="fig7">Figure 7</xref>). Indeed, mouse recombinant CRT has been shown to stimulate the production of TNF-&#x03B1; in mouse peritoneal macrophages by activating I&#x03BA;B&#x03B1;-NF&#x03BA;B and the c-Jun N-terminal kinase (JNK), as well as the production of IL-6 by phosphorylating the extracellular signal-regulated kinase (ERK) (<xref ref-type="bibr" rid="ref15">Duo et al., 2014</xref>).</p>
<p>In addition to the upregulation of IL-6 and TNF-&#x03B1;, rTsCRT stimulated <italic>Nos2</italic> expression and we observed a marginally higher production of nitrites at 48&#x2009;h after rTsCRT treatment (<xref ref-type="supplementary-material" rid="SM3">Supplementary Figure S3</xref>). Accordingly, mammalian recombinant CRT and its fragments can induce the accumulation of nitrites in peritoneal macrophages (<xref ref-type="bibr" rid="ref28">Huang et al., 2013</xref>). NO has been shown to interfere with hRSV replication in both epithelial and macrophage cell lines (<xref ref-type="bibr" rid="ref75">Santiago-Olivares et al., 2019</xref>; <xref ref-type="bibr" rid="ref33">Kao et al., 2001</xref>). Thus, the effects on stimulation of cytokine and chemokine expression, as well as on <italic>Nos2</italic> expression, could explain the observed rTsCRT antiviral activity. The mechanism of action and the receptors involved in mediating the antiviral effects of rTsCRT need to be elucidated. Several receptors have been implicated in binding CRT, including low-density lipoprotein receptor (LRP-1), scavenger receptor A and F, and TLR-4 (<xref ref-type="bibr" rid="ref5">Berwin et al., 2004</xref>; <xref ref-type="bibr" rid="ref6">Berwin et al., 2003</xref>; <xref ref-type="bibr" rid="ref19">Gardai et al., 2003</xref>; <xref ref-type="bibr" rid="ref37">Li et al., 2015</xref>; <xref ref-type="bibr" rid="ref52">Ogden et al., 2001</xref>). Further analysis is required to identify the receptors for rTsCRT and define the signaling pathways involved in its antiviral effect.</p>
</sec>
<sec sec-type="conclusions" id="sec18">
<label>5</label>
<title>Conclusion</title>
<p>hRSV persistent infection altered the expression of many genes. The hRSV model of persistence in macrophages showed downregulation of many genes associated with the antiviral response. Paradoxically, we also observed overexpression of a few antiviral genes, RNA editing enzymes, as well as proinflammatory cytokines and chemokines that induce an M1 phenotype and can control viral replication. Concomitantly, lipid metabolism-related genes, together with <italic>Arg1</italic>, which collectively promote an M2 status were overexpressed. This suggests that hRSV persistence induces a mixed M1/M2 phenotype characterized by a weakened antiviral response. Viral persistence depends on mutual adaptation between the virus and the host-cell to succeed in long-term infection. The seemingly contradictory effects on the macrophage transcriptome may represent virus-induced mechanisms aimed at modulating its own replication while simultaneously evading the immune response. Thus, hRSV persistence appears to involve a balance between pro-inflammatory and anti-inflammatory signals to control viral replication and ensure the survival of both the infected cell and the virus. Remarkably, rTsCRT showed that piM&#x03D5; are not refractory to external stimuli and that the apparent dampening of immune response signaling pathways is still reversible, resulting in a significant reduction in viral genome copies. Our observations have implications for the development of targeted therapies aimed at eliminating or controlling persistent viral infections often associated with immunopathology.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="sec19">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">Supplementary material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec sec-type="author-contributions" id="sec20">
<title>Author contributions</title>
<p>ER-T: Conceptualization, Formal analysis, Investigation, Methodology, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing, Funding acquisition. MF-R: Conceptualization, Formal analysis, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing, Data curation, Investigation, Methodology. CS-O: Investigation, Methodology, Project administration, Writing &#x2013; review &#x0026; editing. MC-R: Investigation, Methodology, Writing &#x2013; review &#x0026; editing, Project administration. VH-B: Investigation, Methodology, Writing &#x2013; review &#x0026; editing. F&#x00C1;-H: Investigation, Methodology, Writing &#x2013; review &#x0026; editing. AF: Resources, Supervision, Writing &#x2013; review &#x0026; editing, Investigation. FM: Conceptualization, Formal analysis, Funding acquisition, Investigation, Project administration, Supervision, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing, Methodology, Validation.</p>
</sec>
<sec sec-type="funding-information" id="sec21">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by Grant PAPIIT IN208420, Direcci&#x00F3;n General de Asuntos Personal Acad&#x00E9;mico (DGAPA), Universidad Nacional Aut&#x00F3;noma de M&#x00E9;xico (UNAM), Mexico and UNAM Postdoctoral Program (POSDOC).</p>
</sec>
<sec sec-type="COI-statement" id="sec22">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="sec23">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="sec24">
<title>Supplementary material</title>
<p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fmicb.2024.1402589/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fmicb.2024.1402589/full#supplementary-material</ext-link></p>
<supplementary-material id="SM1" xlink:href="Image_1.TIF" mimetype="image/tiff" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>SUPPLEMENTARY FIGURE S1</label>
<caption>
<p>Cell viability after rTsCRT treatment. <bold>(A,B)</bold><inline-formula>
<mml:math id="M23">
<mml:mi mathvariant="italic">niM&#x03D5;</mml:mi>
</mml:math>
</inline-formula> treated at 24 and 48&#x2009;h respectively. <bold>(C,D)</bold><inline-formula>
<mml:math id="M24">
<mml:mi mathvariant="italic">piM&#x03D5;</mml:mi>
</mml:math>
</inline-formula> treated at 24 and 48&#x2009;h respectively. rTsCRT, recombinant <italic>T. solium</italic> calreticulin; <inline-formula>
<mml:math id="M25">
<mml:mi mathvariant="italic">niM&#x03D5;</mml:mi>
<mml:mtext>,</mml:mtext>
</mml:math>
</inline-formula><inline-formula>
<mml:math id="M26">
<mml:mi mathvariant="italic">niM&#x03D5;</mml:mi>
<mml:mtext>,</mml:mtext>
</mml:math>
</inline-formula> non-infected macrophages; <inline-formula>
<mml:math id="M27">
<mml:mi mathvariant="italic">piM&#x03D5;</mml:mi>
<mml:mtext>,</mml:mtext>
</mml:math>
</inline-formula> persistently infected macrophages with hRSV; hRSV, human respiratory syncytial virus. <italic>p</italic>-values were calculated using the ANOVA test: &#x002A;&#x2009;=&#x2009;&#x003C;0.05, &#x002A;&#x002A;&#x002A;&#x002A;&#x2009;=&#x2009;&#x2264;0.0001.</p>
</caption>
</supplementary-material>
<supplementary-material id="SM2" xlink:href="Image_2.TIF" mimetype="image/tiff" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>SUPPLEMENTARY FIGURE S2</label>
<caption>
<p>Time-dependent gene expression of macrophages with persistent infection of hRSV treated with 5&#x2009;&#x03BC;g of recombinant calreticulin from <italic>T. solium</italic> (rTsCRT). <bold>(A)</bold> Heatmap of transcripts altered in piMf by rTsCRT treatment at 48&#x2009;h. <bold>(B)</bold> Number of mRNAs deregulated in piMf treated with rTsCRT at 48&#x2009;h. <inline-formula>
<mml:math id="M28">
<mml:mi mathvariant="italic">piM&#x03D5;</mml:mi>
<mml:mtext>,</mml:mtext>
</mml:math>
</inline-formula> persistently infected macrophages with hRSV; hRSV, human respiratory syncytial virus.</p>
</caption>
</supplementary-material>
<supplementary-material id="SM3" xlink:href="Image_3.TIF" mimetype="image/tiff" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>SUPPLEMENTARY FIGURE S3</label>
<caption>
<p>Production of nitrites in <inline-formula>
<mml:math id="M29">
<mml:mi mathvariant="italic">niM&#x03D5;</mml:mi>
</mml:math>
</inline-formula> and <inline-formula>
<mml:math id="M30">
<mml:mi mathvariant="italic">piM&#x03D5;</mml:mi>
</mml:math>
</inline-formula> after treatment with rTsCRT for 6, 24, and 48&#x2009;h. rTsCRT, recombinant <italic>T. solium</italic> calreticulin; <inline-formula>
<mml:math id="M31">
<mml:mi mathvariant="italic">niM&#x03D5;</mml:mi>
<mml:mtext>,</mml:mtext>
</mml:math>
</inline-formula> non-infected macrophages; <inline-formula>
<mml:math id="M32">
<mml:mi mathvariant="italic">piM&#x03D5;</mml:mi>
<mml:mtext>,</mml:mtext>
</mml:math>
</inline-formula> persistently infected macrophages with hRSV; hRSV, human respiratory syncytial virus. <italic>p</italic>-values were calculated by the Mann-Whitney test between <inline-formula>
<mml:math id="M33">
<mml:mi mathvariant="italic">niM&#x03D5;</mml:mi>
</mml:math>
</inline-formula> or <inline-formula>
<mml:math id="M34">
<mml:mi mathvariant="italic">piM&#x03D5;</mml:mi>
</mml:math>
</inline-formula> treated with rTsCRT and their respective control group, none showed statistical significance.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table_1.DOCX" id="SM4" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Data_Sheet_1.XLSX" id="SM5" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Data_Sheet_2.XLSX" id="SM6" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Data_Sheet_3.XLSX" id="SM7" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Data_Sheet_4.XLSX" id="SM8" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Data_Sheet_5.XLSX" id="SM9" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Data_Sheet_6.XLSX" id="SM10" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Antonczyk</surname> <given-names>A.</given-names></name> <name><surname>Krist</surname> <given-names>B.</given-names></name> <name><surname>Sajek</surname> <given-names>M.</given-names></name> <name><surname>Michalska</surname> <given-names>A.</given-names></name> <name><surname>Piaszyk-Borychowska</surname> <given-names>A.</given-names></name> <name><surname>Plens-Galaska</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Direct inhibition of IRF-dependent transcriptional regulatory mechanisms associated with disease</article-title>. <source>Front. Immunol.</source> <volume>10</volume>:<fpage>1176</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2019.01176</pub-id>, PMID: <pub-id pub-id-type="pmid">31178872</pub-id></citation></ref>
<ref id="ref2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Batista-Gonzalez</surname> <given-names>A.</given-names></name> <name><surname>Vidal</surname> <given-names>R.</given-names></name> <name><surname>Criollo</surname> <given-names>A.</given-names></name> <name><surname>Carre&#x00F1;o</surname> <given-names>L. J.</given-names></name></person-group> (<year>2020</year>). <article-title>New insights on the role of lipid metabolism in the metabolic reprogramming of macrophages</article-title>. <source>Front. Immunol.</source> <volume>10</volume>:<fpage>2993</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2019.02993</pub-id>, PMID: <pub-id pub-id-type="pmid">31998297</pub-id></citation></ref>
<ref id="ref3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Battles</surname> <given-names>M. B.</given-names></name> <name><surname>McLellan</surname> <given-names>J. S.</given-names></name></person-group> (<year>2019</year>). <article-title>Respiratory syncytial virus entry and how to block it</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>17</volume>, <fpage>233</fpage>&#x2013;<lpage>245</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41579-019-0149-x</pub-id>, PMID: <pub-id pub-id-type="pmid">30723301</pub-id></citation></ref>
<ref id="ref4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bertrand</surname> <given-names>P.</given-names></name> <name><surname>Lay</surname> <given-names>M. K.</given-names></name> <name><surname>Piedimonte</surname> <given-names>G.</given-names></name> <name><surname>Brockmann</surname> <given-names>P. E.</given-names></name> <name><surname>Palavecino</surname> <given-names>C. E.</given-names></name> <name><surname>Hern&#x00E1;ndez</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Elevated IL-3 and IL-12p40 levels in the lower airway of infants with RSV-induced bronchiolitis correlate with recurrent wheezing</article-title>. <source>Cytokine</source> <volume>76</volume>, <fpage>417</fpage>&#x2013;<lpage>423</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cyto.2015.07.017</pub-id>, PMID: <pub-id pub-id-type="pmid">26299549</pub-id></citation></ref>
<ref id="ref5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berwin</surname> <given-names>B.</given-names></name> <name><surname>Delneste</surname> <given-names>Y.</given-names></name> <name><surname>Lovingood</surname> <given-names>R. V.</given-names></name> <name><surname>Post</surname> <given-names>S. R.</given-names></name> <name><surname>Pizzo</surname> <given-names>S. V.</given-names></name></person-group> (<year>2004</year>). <article-title>SREC-I, a type F scavenger receptor, is an endocytic receptor for calreticulin</article-title>. <source>J. Biol. Chem.</source> <volume>279</volume>, <fpage>51250</fpage>&#x2013;<lpage>51257</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.M406202200</pub-id></citation></ref>
<ref id="ref6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berwin</surname> <given-names>B.</given-names></name> <name><surname>Hart</surname> <given-names>J. P.</given-names></name> <name><surname>Rice</surname> <given-names>S.</given-names></name> <name><surname>Gass</surname> <given-names>C.</given-names></name> <name><surname>Pizzo</surname> <given-names>S. V.</given-names></name> <name><surname>Post</surname> <given-names>S. R.</given-names></name> <etal/></person-group>. (<year>2003</year>). <article-title>Scavenger receptor-A mediates gp96/GRP94 and calreticulin internalization by antigen-presenting cells</article-title>. <source>EMBO J.</source> <volume>22</volume>, <fpage>6127</fpage>&#x2013;<lpage>6136</lpage>. doi: <pub-id pub-id-type="doi">10.1093/emboj/cdg572</pub-id>, PMID: <pub-id pub-id-type="pmid">14609958</pub-id></citation></ref>
<ref id="ref7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bont</surname> <given-names>L.</given-names></name> <name><surname>Ramilo</surname> <given-names>O.</given-names></name></person-group> (<year>2011</year>). <article-title>The relationship between RSV bronchiolitis and recurrent wheeze: the chicken and the egg</article-title>. <source>Early Hum. Dev.</source> <volume>87</volume>, <fpage>S51</fpage>&#x2013;<lpage>S54</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.earlhumdev.2011.01.011</pub-id>, PMID: <pub-id pub-id-type="pmid">21295416</pub-id></citation></ref>
<ref id="ref8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Caldwell</surname> <given-names>R. B.</given-names></name> <name><surname>Toque</surname> <given-names>H. A.</given-names></name> <name><surname>Narayanan</surname> <given-names>S. P.</given-names></name> <name><surname>Caldwell</surname> <given-names>R. W.</given-names></name></person-group> (<year>2015</year>). <article-title>Arginase: an old enzyme with new tricks</article-title>. <source>Trends Pharmacol. Sci.</source> <volume>36</volume>, <fpage>395</fpage>&#x2013;<lpage>405</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tips.2015.03.006</pub-id>, PMID: <pub-id pub-id-type="pmid">25930708</pub-id></citation></ref>
<ref id="ref9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carty</surname> <given-names>M.</given-names></name> <name><surname>Guy</surname> <given-names>C.</given-names></name> <name><surname>Bowie</surname> <given-names>A. G.</given-names></name></person-group> (<year>2021</year>). <article-title>Detection of viral infections by innate immunity</article-title>. <source>Biochem. Pharmacol.</source> <volume>183</volume>:<fpage>114316</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bcp.2020.114316</pub-id></citation></ref>
<ref id="ref10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chawla</surname> <given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Control of macrophage activation and function by PPARs</article-title>. <source>Circ. Res.</source> <volume>106</volume>, <fpage>1559</fpage>&#x2013;<lpage>1569</lpage>. doi: <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.110.216523</pub-id>, PMID: <pub-id pub-id-type="pmid">20508200</pub-id></citation></ref>
<ref id="ref11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coultas</surname> <given-names>J. A.</given-names></name> <name><surname>Smyth</surname> <given-names>R.</given-names></name> <name><surname>Openshaw</surname> <given-names>P. J.</given-names></name></person-group> (<year>2019</year>). <article-title>Respiratory syncytial virus (RSV): a scourge from infancy to old age</article-title>. <source>Thorax</source> <volume>74</volume>, <fpage>986</fpage>&#x2013;<lpage>993</lpage>. doi: <pub-id pub-id-type="doi">10.1136/thoraxjnl-2018-212212</pub-id>, PMID: <pub-id pub-id-type="pmid">31383776</pub-id></citation></ref>
<ref id="ref12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>David</surname> <given-names>M.</given-names></name> <name><surname>Romero</surname> <given-names>G.</given-names></name> <name><surname>Zhang</surname> <given-names>Z. Y.</given-names></name> <name><surname>Dixon</surname> <given-names>J. E.</given-names></name> <name><surname>Larner</surname> <given-names>A. C.</given-names></name></person-group> (<year>1993</year>). <article-title><italic>In vitro</italic> activation of the transcription factor ISGF3 by interferon alpha involves a membrane-associated tyrosine phosphatase and tyrosine kinase</article-title>. <source>J. Biol. Chem.</source> <volume>268</volume>, <fpage>6593</fpage>&#x2013;<lpage>6599</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0021-9258(18)53292-0</pub-id>, PMID: <pub-id pub-id-type="pmid">8454630</pub-id></citation></ref>
<ref id="ref13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Souza</surname> <given-names>G. F.</given-names></name> <name><surname>Muraro</surname> <given-names>S. P.</given-names></name> <name><surname>Santos</surname> <given-names>L. D.</given-names></name> <name><surname>Monteiro</surname> <given-names>A. P. T.</given-names></name> <name><surname>da Silva</surname> <given-names>A. G.</given-names></name> <name><surname>de Souza</surname> <given-names>A. P. D.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Macrophage migration inhibitory factor (MIF) controls cytokine release during respiratory syncytial virus infection in macrophages</article-title>. <source>Inflamm. Res.</source> <volume>68</volume>, <fpage>481</fpage>&#x2013;<lpage>491</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00011-019-01233-z</pub-id>, PMID: <pub-id pub-id-type="pmid">30944975</pub-id></citation></ref>
<ref id="ref14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Diamond</surname> <given-names>M. S.</given-names></name> <name><surname>Farzan</surname> <given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>The broad-spectrum antiviral functions of IFIT and IFITM proteins</article-title>. <source>Nat. Rev. Immunol.</source> <volume>13</volume>, <fpage>46</fpage>&#x2013;<lpage>57</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nri3344</pub-id>, PMID: <pub-id pub-id-type="pmid">23237964</pub-id></citation></ref>
<ref id="ref15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duo</surname> <given-names>C. C.</given-names></name> <name><surname>Gong</surname> <given-names>F. Y.</given-names></name> <name><surname>He</surname> <given-names>X. Y.</given-names></name> <name><surname>Li</surname> <given-names>Y. M.</given-names></name> <name><surname>Wang</surname> <given-names>J.</given-names></name> <name><surname>Zhang</surname> <given-names>J. P.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Soluble calreticulin induces tumor necrosis factor-&#x03B1; (TNF-&#x03B1;) and interleukin (IL)-6 production by macrophages through mitogen-activated protein kinase (MAPK) and NF&#x03BA;B signaling pathways</article-title>. <source>Int. J. Mol. Sci.</source> <volume>15</volume>, <fpage>2916</fpage>&#x2013;<lpage>2928</lpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms15022916</pub-id>, PMID: <pub-id pub-id-type="pmid">24566135</pub-id></citation></ref>
<ref id="ref16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Esperante</surname> <given-names>D.</given-names></name> <name><surname>Flisser</surname> <given-names>A.</given-names></name> <name><surname>Mendlovic</surname> <given-names>F.</given-names></name></person-group> (<year>2023</year>). <article-title>The many faces of parasite calreticulin</article-title>. <source>Front. Immunol.</source> <volume>14</volume>:<fpage>1101390</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2023.1101390</pub-id></citation></ref>
<ref id="ref17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Evangelista</surname> <given-names>J. E.</given-names></name> <name><surname>Xie</surname> <given-names>Z.</given-names></name> <name><surname>Marino</surname> <given-names>G. B.</given-names></name> <name><surname>Nguyen</surname> <given-names>N.</given-names></name> <name><surname>Clarke</surname> <given-names>D. J. B.</given-names></name> <name><surname>Ma&#x2019;ayan</surname> <given-names>A.</given-names></name></person-group> (<year>2023</year>). <article-title>Enrichr-KG: bridging enrichment analysis across multiple libraries</article-title>. <source>Nucleic Acids Res.</source> <volume>51</volume>, <fpage>W168</fpage>&#x2013;<lpage>W179</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkad393</pub-id>, PMID: <pub-id pub-id-type="pmid">37166973</pub-id></citation></ref>
<ref id="ref18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fonseca-Coronado</surname> <given-names>S.</given-names></name> <name><surname>Ruiz-Tovar</surname> <given-names>K.</given-names></name> <name><surname>P&#x00E9;rez-Tapia</surname> <given-names>M.</given-names></name> <name><surname>Mendlovic</surname> <given-names>F.</given-names></name> <name><surname>Flisser</surname> <given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title><italic>Taenia solium</italic>: immune response against oral or systemic immunization with purified recombinant calreticulin in mice</article-title>. <source>Exp. Parasitol.</source> <volume>127</volume>, <fpage>313</fpage>&#x2013;<lpage>317</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.exppara.2010.07.017</pub-id>, PMID: <pub-id pub-id-type="pmid">20691181</pub-id></citation></ref>
<ref id="ref19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gardai</surname> <given-names>S. J.</given-names></name> <name><surname>Xiao</surname> <given-names>Y. Q.</given-names></name> <name><surname>Dickinson</surname> <given-names>M.</given-names></name> <name><surname>Nick</surname> <given-names>J. A.</given-names></name> <name><surname>Voelker</surname> <given-names>D. R.</given-names></name> <name><surname>Greene</surname> <given-names>K. E.</given-names></name> <etal/></person-group>. (<year>2003</year>). <article-title>By binding SIRPalpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation</article-title>. <source>Cell</source> <volume>115</volume>, <fpage>13</fpage>&#x2013;<lpage>23</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0092-8674(03)00758-X</pub-id></citation></ref>
<ref id="ref20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gazzinelli-Guimaraes</surname> <given-names>P. H.</given-names></name> <name><surname>Nutman</surname> <given-names>T. B.</given-names></name></person-group> (<year>2018</year>). <article-title>Helminth parasites and immune regulation</article-title>. <source>F1000Res.</source> <volume>7</volume>:<fpage>Faculty Rev-1685</fpage>. doi: <pub-id pub-id-type="doi">10.12688/f1000research.15596.1</pub-id></citation></ref>
<ref id="ref21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gelebart</surname> <given-names>P.</given-names></name> <name><surname>Opas</surname> <given-names>M.</given-names></name> <name><surname>Michalak</surname> <given-names>M.</given-names></name></person-group> (<year>2005</year>). <article-title>Calreticulin, a Ca<sup>2+</sup>-binding chaperone of the endoplasmic reticulum</article-title>. <source>Int. J. Biochem. Cell Biol.</source> <volume>37</volume>, <fpage>260</fpage>&#x2013;<lpage>266</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.biocel.2004.02.030</pub-id></citation></ref>
<ref id="ref22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gold</surname> <given-names>L. I.</given-names></name> <name><surname>Eggleton</surname> <given-names>P.</given-names></name> <name><surname>Sweetwyne</surname> <given-names>M. T.</given-names></name> <name><surname>Van Duyn</surname> <given-names>L. B.</given-names></name> <name><surname>Greives</surname> <given-names>M. R.</given-names></name> <name><surname>Naylor</surname> <given-names>S. M.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Calreticulin: non-endoplasmic reticulum functions in physiology and disease</article-title>. <source>FASEB J.</source> <volume>24</volume>, <fpage>665</fpage>&#x2013;<lpage>683</lpage>. doi: <pub-id pub-id-type="doi">10.1096/fj.09-145482</pub-id>, PMID: <pub-id pub-id-type="pmid">19940256</pub-id></citation></ref>
<ref id="ref23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grandvaux</surname> <given-names>N.</given-names></name> <name><surname>Servant</surname> <given-names>M. J.</given-names></name> <name><surname>ten Oever</surname> <given-names>B.</given-names></name> <name><surname>Sen</surname> <given-names>G. C.</given-names></name> <name><surname>Balachandran</surname> <given-names>S.</given-names></name> <name><surname>Barber</surname> <given-names>G. N.</given-names></name> <etal/></person-group>. (<year>2002</year>). <article-title>Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes</article-title>. <source>J. Virol.</source> <volume>76</volume>, <fpage>5532</fpage>&#x2013;<lpage>5539</lpage>. doi: <pub-id pub-id-type="doi">10.1128/JVI.76.11.5532-5539.2002</pub-id>, PMID: <pub-id pub-id-type="pmid">11991981</pub-id></citation></ref>
<ref id="ref24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Griffin</surname> <given-names>D. E.</given-names></name></person-group> (<year>2022</year>). <article-title>Why does viral RNA sometimes persist after recovery from acute infections?</article-title> <source>PLoS Biol.</source> <volume>20</volume>:<fpage>e3001687</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pbio.3001687</pub-id>, PMID: <pub-id pub-id-type="pmid">35648781</pub-id></citation></ref>
<ref id="ref25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hashimoto</surname> <given-names>K.</given-names></name> <name><surname>Ishibashi</surname> <given-names>K.</given-names></name> <name><surname>Ishioka</surname> <given-names>K.</given-names></name> <name><surname>Zhao</surname> <given-names>D.</given-names></name> <name><surname>Sato</surname> <given-names>M.</given-names></name> <name><surname>Ohara</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2009</year>). <article-title>RSV replication is attenuated by counteracting expression of the suppressor of cytokine signaling (SOCS) molecules</article-title>. <source>Virology</source> <volume>391</volume>, <fpage>162</fpage>&#x2013;<lpage>170</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.virol.2009.06.026</pub-id>, PMID: <pub-id pub-id-type="pmid">19595407</pub-id></citation></ref>
<ref id="ref26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname> <given-names>C.</given-names></name> <name><surname>Qiu</surname> <given-names>X.</given-names></name> <name><surname>Li</surname> <given-names>Y.</given-names></name> <name><surname>Huang</surname> <given-names>Q.</given-names></name> <name><surname>Zhong</surname> <given-names>Z.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Functional analysis of recombinant calreticulin fragment 39-272: implications for immunobiological activities of calreticulin in health and disease</article-title>. <source>J. Immunol.</source> <volume>185</volume>, <fpage>4561</fpage>&#x2013;<lpage>4569</lpage>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.1000536</pub-id>, PMID: <pub-id pub-id-type="pmid">20855873</pub-id></citation></ref>
<ref id="ref27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>D. W.</given-names></name> <name><surname>Sherman</surname> <given-names>B. T.</given-names></name> <name><surname>Lempicki</surname> <given-names>R. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources</article-title>. <source>Nat. Protoc.</source> <volume>4</volume>, <fpage>44</fpage>&#x2013;<lpage>57</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nprot.2008.211</pub-id>, PMID: <pub-id pub-id-type="pmid">19131956</pub-id></citation></ref>
<ref id="ref28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>S. H.</given-names></name> <name><surname>Zhao</surname> <given-names>L. X.</given-names></name> <name><surname>Hong</surname> <given-names>C.</given-names></name> <name><surname>Duo</surname> <given-names>C. C.</given-names></name> <name><surname>Guo</surname> <given-names>B. N.</given-names></name> <name><surname>Zhang</surname> <given-names>L. J.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Self-Oligomerization is essential for enhanced immunological activities of soluble recombinant calreticulin</article-title>. <source>PLoS One</source> <volume>8</volume>:<fpage>e64951</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0064951</pub-id></citation></ref>
<ref id="ref29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>Z.</given-names></name> <name><surname>Mak</surname> <given-names>T. W.</given-names></name> <name><surname>Sen</surname> <given-names>G.</given-names></name> <name><surname>Li</surname> <given-names>X.</given-names></name></person-group> (<year>2004</year>). <article-title>Toll-like receptor 3-mediated activation of NF-&#x03BA;B and IRF3 diverges at toll-IL-1 receptor domain-containing adapter inducing IFN-&#x03B2;</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>101</volume>, <fpage>3533</fpage>&#x2013;<lpage>3538</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.0308496101</pub-id>, PMID: <pub-id pub-id-type="pmid">14982987</pub-id></citation></ref>
<ref id="ref30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname> <given-names>D.</given-names></name> <name><surname>Guo</surname> <given-names>H.</given-names></name> <name><surname>Bu</surname> <given-names>S. Y.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Hannaford</surname> <given-names>J.</given-names></name> <name><surname>Mashek</surname> <given-names>D. G.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Lipocalin 2 is a selective modulator of peroxisome proliferator-activated receptor-gamma activation and function in lipid homeostasis and energy expenditure</article-title>. <source>FASEB J.</source> <volume>25</volume>, <fpage>754</fpage>&#x2013;<lpage>764</lpage>. doi: <pub-id pub-id-type="doi">10.1096/fj.10-165175</pub-id>, PMID: <pub-id pub-id-type="pmid">20974668</pub-id></citation></ref>
<ref id="ref31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname> <given-names>J. E.</given-names></name> <name><surname>Gonzales</surname> <given-names>R. A.</given-names></name> <name><surname>Olson</surname> <given-names>S. J.</given-names></name> <name><surname>Wright</surname> <given-names>P. F.</given-names></name> <name><surname>Graham</surname> <given-names>B. S.</given-names></name></person-group> (<year>2007</year>). <article-title>The histopathology of fatal untreated human respiratory syncytial virus infection</article-title>. <source>Mod. Pathol.</source> <volume>20</volume>, <fpage>108</fpage>&#x2013;<lpage>119</lpage>. doi: <pub-id pub-id-type="doi">10.1038/modpathol.3800725</pub-id>, PMID: <pub-id pub-id-type="pmid">17143259</pub-id></citation></ref>
<ref id="ref32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kamata</surname> <given-names>H.</given-names></name> <name><surname>Tsuchiya</surname> <given-names>Y.</given-names></name> <name><surname>Asano</surname> <given-names>T.</given-names></name></person-group> (<year>2010</year>). <article-title>I&#x03BA;B&#x03B2; is a positive and negative regulator of NF-&#x03BA;B activity during inflammation</article-title>. <source>Cell Res.</source> <volume>20</volume>, <fpage>1178</fpage>&#x2013;<lpage>1180</lpage>. doi: <pub-id pub-id-type="doi">10.1038/cr.2010.147</pub-id>, PMID: <pub-id pub-id-type="pmid">20975741</pub-id></citation></ref>
<ref id="ref33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kao</surname> <given-names>Y. J.</given-names></name> <name><surname>Piedra</surname> <given-names>P. A.</given-names></name> <name><surname>Larsen</surname> <given-names>G. L.</given-names></name> <name><surname>Colasurdo</surname> <given-names>G. N.</given-names></name></person-group> (<year>2001</year>). <article-title>Induction and regulation of nitric oxide synthase in airway epithelial cells by respiratory syncytial virus</article-title>. <source>Am. J. Respir. Crit. Care Med.</source> <volume>163</volume>, <fpage>532</fpage>&#x2013;<lpage>539</lpage>. doi: <pub-id pub-id-type="doi">10.1164/ajrccm.163.2.9912068</pub-id>, PMID: <pub-id pub-id-type="pmid">11179135</pub-id></citation></ref>
<ref id="ref34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname> <given-names>M.</given-names></name> <name><surname>Ishioka</surname> <given-names>T.</given-names></name> <name><surname>Kita</surname> <given-names>H.</given-names></name> <name><surname>Kozawa</surname> <given-names>K.</given-names></name> <name><surname>Hayashi</surname> <given-names>Y.</given-names></name> <name><surname>Kimura</surname> <given-names>H.</given-names></name></person-group> (<year>2012</year>). <article-title>Eosinophil granular proteins damage bronchial epithelial cells infected with respiratory syncytial virus</article-title>. <source>Int. Arch. Allergy Immunol.</source> <volume>158</volume>, <fpage>11</fpage>&#x2013;<lpage>18</lpage>. doi: <pub-id pub-id-type="doi">10.1159/000337752</pub-id>, PMID: <pub-id pub-id-type="pmid">22627361</pub-id></citation></ref>
<ref id="ref35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kawai</surname> <given-names>T.</given-names></name> <name><surname>Akira</surname> <given-names>S.</given-names></name></person-group> (<year>2006</year>). <article-title>Innate immune recognition of viral infection</article-title>. <source>Nat. Immunol.</source> <volume>7</volume>, <fpage>131</fpage>&#x2013;<lpage>137</lpage>. doi: <pub-id pub-id-type="doi">10.1038/ni1303</pub-id></citation></ref>
<ref id="ref36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kieler</surname> <given-names>M.</given-names></name> <name><surname>Hofmann</surname> <given-names>M.</given-names></name> <name><surname>Schabbauer</surname> <given-names>G.</given-names></name></person-group> (<year>2021</year>). <article-title>More than just protein building blocks: how amino acids and related metabolic pathways fuel macrophage polarization</article-title>. <source>FEBS J.</source> <volume>288</volume>, <fpage>3694</fpage>&#x2013;<lpage>3714</lpage>. doi: <pub-id pub-id-type="doi">10.1111/febs.15715</pub-id>, PMID: <pub-id pub-id-type="pmid">33460504</pub-id></citation></ref>
<ref id="ref37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>Y.</given-names></name> <name><surname>Zeng</surname> <given-names>X.</given-names></name> <name><surname>He</surname> <given-names>L.</given-names></name> <name><surname>Yuan</surname> <given-names>H.</given-names></name></person-group> (<year>2015</year>). <article-title>Dendritic cell activation and maturation induced by recombinant calreticulin fragment 39-272</article-title>. <source>Int. J. Clin. Exp. Med.</source> <volume>8</volume>, <fpage>7288</fpage>&#x2013;<lpage>7296</lpage>, PMID: <pub-id pub-id-type="pmid">26221268</pub-id></citation></ref>
<ref id="ref38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>R.</given-names></name> <name><surname>Zhou</surname> <given-names>R.</given-names></name> <name><surname>Wang</surname> <given-names>H.</given-names></name> <name><surname>Li</surname> <given-names>W.</given-names></name> <name><surname>Pan</surname> <given-names>M.</given-names></name> <name><surname>Yao</surname> <given-names>X.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Gut microbiota-stimulated cathepsin K secretion mediates TLR4-dependent M2 macrophage polarization and promotes tumor metastasis in colorectal cancer</article-title>. <source>Cell Death Differ.</source> <volume>26</volume>, <fpage>2447</fpage>&#x2013;<lpage>2463</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41418-019-0312-y</pub-id>, PMID: <pub-id pub-id-type="pmid">30850734</pub-id></citation></ref>
<ref id="ref39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname> <given-names>H. J.</given-names></name> <name><surname>Lee</surname> <given-names>S.</given-names></name> <name><surname>Lee</surname> <given-names>K. S.</given-names></name> <name><surname>Park</surname> <given-names>J. H.</given-names></name> <name><surname>Jang</surname> <given-names>Y.</given-names></name> <name><surname>Lee</surname> <given-names>E. J.</given-names></name> <etal/></person-group>. (<year>2006</year>). <article-title>PPARgamma activation induces CD36 expression and stimulates foam cell like changes in rVSMCs</article-title>. <source>Prostaglandins Other Lipid Mediat.</source> <volume>80</volume>, <fpage>165</fpage>&#x2013;<lpage>174</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.prostaglandins.2006.06.006</pub-id>, PMID: <pub-id pub-id-type="pmid">16939881</pub-id></citation></ref>
<ref id="ref40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname> <given-names>K. J.</given-names></name> <name><surname>Schmittgen</surname> <given-names>T. D.</given-names></name></person-group> (<year>2001</year>). <article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2<sup>&#x2212;&#x0394;&#x0394;CT</sup> method</article-title>. <source>Methods</source> <volume>25</volume>, <fpage>402</fpage>&#x2013;<lpage>408</lpage>. doi: <pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id></citation></ref>
<ref id="ref41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>L&#x00F3;pez</surname> <given-names>N. C.</given-names></name> <name><surname>Valck</surname> <given-names>C.</given-names></name> <name><surname>Ram&#x00ED;rez</surname> <given-names>G.</given-names></name> <name><surname>Rodr&#x00ED;guez</surname> <given-names>M.</given-names></name> <name><surname>Ribeiro</surname> <given-names>C.</given-names></name> <name><surname>Orellana</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Antiangiogenic and antitumor effects of <italic>Trypanosoma cruzi</italic> calreticulin</article-title>. <source>PLoS Negl. Trop. Dis.</source> <volume>4</volume>:<fpage>e730</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pntd.0000730</pub-id>, PMID: <pub-id pub-id-type="pmid">20625551</pub-id></citation></ref>
<ref id="ref42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Makris</surname> <given-names>S.</given-names></name> <name><surname>Bajorek</surname> <given-names>M.</given-names></name> <name><surname>Culley</surname> <given-names>F. J.</given-names></name> <name><surname>Goritzka</surname> <given-names>M.</given-names></name> <name><surname>Johansson</surname> <given-names>C.</given-names></name></person-group> (<year>2016</year>). <article-title>Alveolar macrophages can control respiratory syncytial virus infection in the absence of type I interferons</article-title>. <source>J. Innate Immun.</source> <volume>8</volume>, <fpage>452</fpage>&#x2013;<lpage>463</lpage>. doi: <pub-id pub-id-type="doi">10.1159/000446824</pub-id>, PMID: <pub-id pub-id-type="pmid">27423203</pub-id></citation></ref>
<ref id="ref43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x00ED;</surname> <given-names>I.</given-names></name> <name><surname>L&#x00ED;ndez</surname> <given-names>A. A.</given-names></name> <name><surname>Reith</surname> <given-names>W.</given-names></name></person-group> (<year>2021</year>). <article-title>Arginine-dependent immune responses</article-title>. <source>Cell. Mol. Life Sci.</source> <volume>78</volume>, <fpage>5303</fpage>&#x2013;<lpage>5324</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00018-021-03828-4</pub-id>, PMID: <pub-id pub-id-type="pmid">34037806</pub-id></citation></ref>
<ref id="ref44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x00ED;nez</surname> <given-names>I.</given-names></name> <name><surname>Lombard&#x00ED;a</surname> <given-names>L.</given-names></name> <name><surname>Herranz</surname> <given-names>C.</given-names></name> <name><surname>Garc&#x00ED;a-Barreno</surname> <given-names>B.</given-names></name> <name><surname>Dom&#x00ED;nguez</surname> <given-names>O.</given-names></name> <name><surname>Melero</surname> <given-names>J. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Cultures of HEp-2 cells persistently infected by human respiratory syncytial virus differ in chemokine expression and resistance to apoptosis as compared to lytic infections of the same cell type</article-title>. <source>Virology</source> <volume>388</volume>, <fpage>31</fpage>&#x2013;<lpage>41</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.virol.2009.03.008</pub-id>, PMID: <pub-id pub-id-type="pmid">19345972</pub-id></citation></ref>
<ref id="ref45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsushita</surname> <given-names>K.</given-names></name> <name><surname>Takeuchi</surname> <given-names>O.</given-names></name> <name><surname>Standley</surname> <given-names>D. M.</given-names></name> <name><surname>Kumagai</surname> <given-names>Y.</given-names></name> <name><surname>Kawagoe</surname> <given-names>T.</given-names></name> <name><surname>Miyake</surname> <given-names>T.</given-names></name> <etal/></person-group>. (<year>2009</year>). <article-title>Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay</article-title>. <source>Nature</source> <volume>458</volume>, <fpage>1185</fpage>&#x2013;<lpage>1190</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature07924</pub-id>, PMID: <pub-id pub-id-type="pmid">19322177</pub-id></citation></ref>
<ref id="ref46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McNamara</surname> <given-names>P. S.</given-names></name> <name><surname>Flanagan</surname> <given-names>B. F.</given-names></name> <name><surname>Selby</surname> <given-names>A. M.</given-names></name> <name><surname>Hart</surname> <given-names>C. A.</given-names></name> <name><surname>Smyth</surname> <given-names>R. L.</given-names></name></person-group> (<year>2004</year>). <article-title>Pro-and anti-inflammatory responses in respiratory syncytial virus bronchiolitis</article-title>. <source>Eur. Respir. J.</source> <volume>23</volume>, <fpage>106</fpage>&#x2013;<lpage>112</lpage>. doi: <pub-id pub-id-type="doi">10.1183/09031936.03.00048103</pub-id>, PMID: <pub-id pub-id-type="pmid">14738241</pub-id></citation></ref>
<ref id="ref47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mej&#x00ED;as</surname> <given-names>A.</given-names></name> <name><surname>Ch&#x00E1;vez-Bueno</surname> <given-names>S.</given-names></name> <name><surname>Ramilo</surname> <given-names>O.</given-names></name></person-group> (<year>2005</year>). <article-title>Respiratory syncytial virus pneumonia: mechanisms of inflammation and prolonged airway hyperresponsiveness</article-title>. <source>Curr. Opin. Infect. Dis.</source> <volume>18</volume>, <fpage>199</fpage>&#x2013;<lpage>204</lpage>. doi: <pub-id pub-id-type="doi">10.1097/01.qco.0000168378.07110.72</pub-id>, PMID: <pub-id pub-id-type="pmid">15864095</pub-id></citation></ref>
<ref id="ref48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mendlovic</surname> <given-names>F.</given-names></name> <name><surname>Ostoa-Saloma</surname> <given-names>P.</given-names></name> <name><surname>Sol&#x00ED;s</surname> <given-names>C. F.</given-names></name> <name><surname>Mart&#x00ED;nez-Oca&#x00F1;a</surname> <given-names>J.</given-names></name> <name><surname>Flisser</surname> <given-names>A.</given-names></name> <name><surname>Laclette</surname> <given-names>J. P.</given-names></name></person-group> (<year>2004</year>). <article-title>Cloning, characterization, and functional expression of <italic>Taenia solium</italic> calreticulin</article-title>. <source>J. Parasitol.</source> <volume>90</volume>, <fpage>891</fpage>&#x2013;<lpage>893</lpage>. doi: <pub-id pub-id-type="doi">10.1645/GE-3325RN</pub-id>, PMID: <pub-id pub-id-type="pmid">15357095</pub-id></citation></ref>
<ref id="ref49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Michalak</surname> <given-names>M.</given-names></name> <name><surname>Groenendyk</surname> <given-names>J.</given-names></name> <name><surname>Szabo</surname> <given-names>E.</given-names></name> <name><surname>Gold</surname> <given-names>L. I.</given-names></name> <name><surname>Opas</surname> <given-names>M.</given-names></name></person-group> (<year>2009</year>). <article-title>Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulum</article-title>. <source>Biochem. J.</source> <volume>417</volume>, <fpage>651</fpage>&#x2013;<lpage>666</lpage>. doi: <pub-id pub-id-type="doi">10.1042/BJ20081847</pub-id>, PMID: <pub-id pub-id-type="pmid">19133842</pub-id></citation></ref>
<ref id="ref50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neuzil</surname> <given-names>K. M.</given-names></name> <name><surname>Tang</surname> <given-names>Y. W.</given-names></name> <name><surname>Graham</surname> <given-names>B. S.</given-names></name></person-group> (<year>1996</year>). <article-title>Protective role of TNF-alpha in respiratory syncytial virus infection <italic>in vitro</italic> and <italic>in vivo</italic></article-title>. <source>Am. J. Med. Sci.</source> <volume>311</volume>, <fpage>201</fpage>&#x2013;<lpage>204</lpage>. doi: <pub-id pub-id-type="doi">10.1097/00000441-199605000-00001</pub-id>, PMID: <pub-id pub-id-type="pmid">8615393</pub-id></citation></ref>
<ref id="ref51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nilsson-Payant</surname> <given-names>B. E.</given-names></name> <name><surname>Uhl</surname> <given-names>S.</given-names></name> <name><surname>Grimont</surname> <given-names>A.</given-names></name> <name><surname>Doane</surname> <given-names>A. S.</given-names></name> <name><surname>Cohen</surname> <given-names>P.</given-names></name> <name><surname>Patel</surname> <given-names>R. S.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>The NF-&#x03BA;B transcriptional footprint is essential for SARS-CoV-2 replication</article-title>. <source>J. Virol.</source> <volume>95</volume>:<fpage>e0125721</fpage>. doi: <pub-id pub-id-type="doi">10.1128/JVI.01257-21</pub-id></citation></ref>
<ref id="ref52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ogden</surname> <given-names>C. A.</given-names></name> <name><surname>de Cathelineau</surname> <given-names>A.</given-names></name> <name><surname>Hoffmann</surname> <given-names>P. R.</given-names></name> <name><surname>Bratton</surname> <given-names>D.</given-names></name> <name><surname>Ghebrehiwet</surname> <given-names>B.</given-names></name> <name><surname>Fadok</surname> <given-names>V. A.</given-names></name> <etal/></person-group>. (<year>2001</year>). <article-title>C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells</article-title>. <source>J. Exp. Med.</source> <volume>194</volume>, <fpage>781</fpage>&#x2013;<lpage>796</lpage>. doi: <pub-id pub-id-type="doi">10.1084/jem.194.6.781</pub-id>, PMID: <pub-id pub-id-type="pmid">11560994</pub-id></citation></ref>
<ref id="ref53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ouyang</surname> <given-names>Y.</given-names></name> <name><surname>Liao</surname> <given-names>H.</given-names></name> <name><surname>Hu</surname> <given-names>Y.</given-names></name> <name><surname>Luo</surname> <given-names>K.</given-names></name> <name><surname>Hu</surname> <given-names>S.</given-names></name> <name><surname>Zhu</surname> <given-names>H.</given-names></name></person-group> (<year>2022</year>). <article-title>Innate immune evasion by human respiratory syncytial virus</article-title>. <source>Front. Microbiol.</source> <volume>13</volume>:<fpage>865592</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2022.865592</pub-id>, PMID: <pub-id pub-id-type="pmid">35308390</pub-id></citation></ref>
<ref id="ref54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pahl</surname> <given-names>H. L.</given-names></name></person-group> (<year>1999</year>). <article-title>Activators and target genes of Rel/NF-&#x03BA;B transcription factors</article-title>. <source>Oncogene</source> <volume>18</volume>, <fpage>6853</fpage>&#x2013;<lpage>6866</lpage>. doi: <pub-id pub-id-type="doi">10.1038/sj.onc.1203239</pub-id></citation></ref>
<ref id="ref55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pei</surname> <given-names>J.</given-names></name> <name><surname>Beri</surname> <given-names>N. R.</given-names></name> <name><surname>Zou</surname> <given-names>A. J.</given-names></name> <name><surname>Hubel</surname> <given-names>P.</given-names></name> <name><surname>Dorando</surname> <given-names>H. K.</given-names></name> <name><surname>Bergant</surname> <given-names>V.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Nuclear-localized human respiratory syncytial virus NS1 protein modulates host gene transcription</article-title>. <source>Cell Rep.</source> <volume>37</volume>:<fpage>109803</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.celrep.2021.109803</pub-id></citation></ref>
<ref id="ref56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pe&#x00F1;a &#x00C1;lvarez</surname> <given-names>J.</given-names></name> <name><surname>Teneb</surname> <given-names>J.</given-names></name> <name><surname>Maldonado</surname> <given-names>I.</given-names></name> <name><surname>Weinberger</surname> <given-names>K.</given-names></name> <name><surname>Rosas</surname> <given-names>C.</given-names></name> <name><surname>Lemus</surname> <given-names>D.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Structural bases that underline <italic>Trypanosoma cruzi</italic> calreticulin proinfective, antiangiogenic and antitumor properties</article-title>. <source>Immunobiology</source> <volume>225</volume>:<fpage>151863</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.imbio.2019.10.012</pub-id>, PMID: <pub-id pub-id-type="pmid">31732192</pub-id></citation></ref>
<ref id="ref57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Piedimonte</surname> <given-names>G.</given-names></name> <name><surname>Perez</surname> <given-names>M. K.</given-names></name></person-group> (<year>2014</year>). <article-title>Alternative mechanisms for respiratory syncytial virus (RSV) infection and persistence: could RSV be transmitted through the placenta and persist into developing fetal lungs?</article-title> <source>Curr. Opin. Pharmacol.</source> <volume>16</volume>, <fpage>82</fpage>&#x2013;<lpage>88</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.coph.2014.03.008</pub-id>, PMID: <pub-id pub-id-type="pmid">24810284</pub-id></citation></ref>
<ref id="ref58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ram&#x00ED;rez-Toloza</surname> <given-names>G.</given-names></name> <name><surname>Aguilar-Guzm&#x00E1;n</surname> <given-names>L.</given-names></name> <name><surname>Valck</surname> <given-names>C.</given-names></name> <name><surname>Ferreira</surname> <given-names>V. P.</given-names></name> <name><surname>Ferreira</surname> <given-names>A.</given-names></name></person-group> (<year>2020</year>). <article-title>The interactions of parasite calreticulin with initial complement components: consequences in immunity and virulence</article-title>. <source>Front. Immunol.</source> <volume>11</volume>:<fpage>1561</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2020.01561</pub-id>, PMID: <pub-id pub-id-type="pmid">32793217</pub-id></citation></ref>
<ref id="ref59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ram&#x00ED;rez-Toloza</surname> <given-names>G.</given-names></name> <name><surname>Ferreira</surname> <given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Trypanosoma cruzi evades the complement system as an efficient strategy to survive in the mammalian host: the specific roles of host/parasite molecules and <italic>Trypanosoma cruzi</italic> calreticulin</article-title>. <source>Front. Microbiol.</source> <volume>8</volume>:<fpage>1667</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2017.01667</pub-id>, PMID: <pub-id pub-id-type="pmid">28919885</pub-id></citation></ref>
<ref id="ref60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rath</surname> <given-names>M.</given-names></name> <name><surname>M&#x00FC;ller</surname> <given-names>I.</given-names></name> <name><surname>Kropf</surname> <given-names>P.</given-names></name> <name><surname>Closs</surname> <given-names>E. I.</given-names></name> <name><surname>Munder</surname> <given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>Metabolism via arginase or nitric oxide synthase: two competing arginine pathways in macrophages</article-title>. <source>Front. Immunol.</source> <volume>5</volume>:<fpage>532</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2014.00532</pub-id></citation></ref>
<ref id="ref61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ravi</surname> <given-names>L. I.</given-names></name> <name><surname>Li</surname> <given-names>L.</given-names></name> <name><surname>Sutejo</surname> <given-names>R.</given-names></name> <name><surname>Chen</surname> <given-names>H.</given-names></name> <name><surname>Wong</surname> <given-names>P. S.</given-names></name> <name><surname>Tan</surname> <given-names>B. H.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>A systems-based approach to analyse the host response in murine lung macrophages challenged with respiratory syncytial virus</article-title>. <source>BMC Genomics</source> <volume>14</volume>:<fpage>190</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1471-2164-14-190</pub-id>, PMID: <pub-id pub-id-type="pmid">23506210</pub-id></citation></ref>
<ref id="ref62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rex</surname> <given-names>D. A. B.</given-names></name> <name><surname>Agarwal</surname> <given-names>N.</given-names></name> <name><surname>TSK</surname> <given-names>P.</given-names></name> <name><surname>Kandasamy</surname> <given-names>R. K.</given-names></name> <name><surname>Subbannayya</surname> <given-names>Y.</given-names></name> <name><surname>Pinto</surname> <given-names>S. M.</given-names></name></person-group> (<year>2020</year>). <article-title>A comprehensive pathway map of IL-18-mediated signalling</article-title>. <source>J. Cell Commun. Signal.</source> <volume>14</volume>, <fpage>257</fpage>&#x2013;<lpage>266</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12079-019-00544-4</pub-id>, PMID: <pub-id pub-id-type="pmid">31863285</pub-id></citation></ref>
<ref id="ref63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rivera-Toledo</surname> <given-names>E.</given-names></name> <name><surname>Salido-Guadarrama</surname> <given-names>I.</given-names></name> <name><surname>Rodr&#x00ED;guez-Dorantes</surname> <given-names>M.</given-names></name> <name><surname>Torres-Gonz&#x00E1;lez</surname> <given-names>L.</given-names></name> <name><surname>Santiago-Olivares</surname> <given-names>C.</given-names></name> <name><surname>G&#x00F3;mez</surname> <given-names>B.</given-names></name></person-group> (<year>2017</year>). <article-title>Conditioned medium from persistently RSV-infected macrophages alters transcriptional profile and inflammatory response of non-infected macrophages</article-title>. <source>Virus Res.</source> <volume>230</volume>, <fpage>29</fpage>&#x2013;<lpage>37</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.virusres.2017.01.001</pub-id>, PMID: <pub-id pub-id-type="pmid">28069520</pub-id></citation></ref>
<ref id="ref64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rivera-Toledo</surname> <given-names>E.</given-names></name> <name><surname>Torres-Gonz&#x00E1;lez</surname> <given-names>L.</given-names></name> <name><surname>G&#x00F3;mez</surname> <given-names>B.</given-names></name></person-group> (<year>2015</year>). <article-title>Respiratory syncytial virus persistence in murine macrophages impairs IFN-&#x03B2; response but not synthesis</article-title>. <source>Viruses</source> <volume>7</volume>, <fpage>5361</fpage>&#x2013;<lpage>5374</lpage>. doi: <pub-id pub-id-type="doi">10.3390/v7102879</pub-id></citation></ref>
<ref id="ref65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roe</surname> <given-names>M. F. E.</given-names></name> <name><surname>Bloxham</surname> <given-names>D. M.</given-names></name> <name><surname>Cowburn</surname> <given-names>A. S.</given-names></name> <name><surname>O&#x2019;Donnell</surname> <given-names>D. R.</given-names></name></person-group> (<year>2011</year>). <article-title>Changes in helper lymphocyte chemokine receptor expression and elevation of IP-10 during acute respiratory syncytial virus infection in infants</article-title>. <source>Pediatr. Allergy Immunol.</source> <volume>22</volume>, <fpage>229</fpage>&#x2013;<lpage>234</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1399-3038.2010.01032.x</pub-id>, PMID: <pub-id pub-id-type="pmid">20561238</pub-id></citation></ref>
<ref id="ref66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ronaghan</surname> <given-names>N. J.</given-names></name> <name><surname>Soo</surname> <given-names>M.</given-names></name> <name><surname>Pena</surname> <given-names>U.</given-names></name> <name><surname>Tellis</surname> <given-names>M.</given-names></name> <name><surname>Duan</surname> <given-names>W.</given-names></name> <name><surname>Tabatabaei-Zavareh</surname> <given-names>N.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>M1-like, but not M0-or M2-like, macrophages, reduce RSV infection of primary bronchial epithelial cells in a media-dependent fashion</article-title>. <source>PLoS One</source> <volume>17</volume>:<fpage>e0276013</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0276013</pub-id>, PMID: <pub-id pub-id-type="pmid">36228018</pub-id></citation></ref>
<ref id="ref67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rosas-Salazar</surname> <given-names>C.</given-names></name> <name><surname>Chirkova</surname> <given-names>T.</given-names></name> <name><surname>Gebretsadik</surname> <given-names>T.</given-names></name> <name><surname>Chappell</surname> <given-names>J. D.</given-names></name> <name><surname>Peebles</surname> <given-names>R. S.</given-names></name> <name><surname>Dupont</surname> <given-names>W. D.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Respiratory syncytial virus infection during infancy and asthma during childhood in the USA (INSPIRE): a population-based, prospective birth cohort study</article-title>. <source>Lancet</source> <volume>401</volume>, <fpage>1669</fpage>&#x2013;<lpage>1680</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(23)00811-5</pub-id>, PMID: <pub-id pub-id-type="pmid">37086744</pub-id></citation></ref>
<ref id="ref68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ruiz-G&#x00F3;mez</surname> <given-names>X.</given-names></name> <name><surname>V&#x00E1;zquez-P&#x00E9;rez</surname> <given-names>J. A.</given-names></name> <name><surname>Flores-Herrera</surname> <given-names>O.</given-names></name> <name><surname>Esparza-Perusqu&#x00ED;a</surname> <given-names>M.</given-names></name> <name><surname>Santiago-Olivares</surname> <given-names>C.</given-names></name> <name><surname>Gaona-Bernal</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Steady-state persistence of respiratory syncytial virus in a macrophage-like cell line and sequence analysis of the persistent viral genome</article-title>. <source>Virus Res.</source> <volume>297</volume>:<fpage>198367</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.virusres.2021.198367</pub-id>, PMID: <pub-id pub-id-type="pmid">33684421</pub-id></citation></ref>
<ref id="ref69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname> <given-names>C. D.</given-names></name> <name><surname>Unger</surname> <given-names>S. A.</given-names></name> <name><surname>Walton</surname> <given-names>M.</given-names></name> <name><surname>Schwarze</surname> <given-names>J.</given-names></name></person-group> (<year>2017</year>). <article-title>The human immune response to respiratory syncytial virus infection</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>30</volume>, <fpage>481</fpage>&#x2013;<lpage>502</lpage>. doi: <pub-id pub-id-type="doi">10.1128/CMR.00090-16</pub-id>, PMID: <pub-id pub-id-type="pmid">28179378</pub-id></citation></ref>
<ref id="ref70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rutigliano</surname> <given-names>J. A.</given-names></name> <name><surname>Graham</surname> <given-names>B. S.</given-names></name></person-group> (<year>2004</year>). <article-title>Prolonged production of TNF-alpha exacerbates illness during respiratory syncytial virus infection</article-title>. <source>J. Immunol.</source> <volume>173</volume>, <fpage>3408</fpage>&#x2013;<lpage>3417</lpage>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.173.5.3408</pub-id>, PMID: <pub-id pub-id-type="pmid">15322205</pub-id></citation></ref>
<ref id="ref71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ryan</surname> <given-names>S. M.</given-names></name> <name><surname>Eichenberger</surname> <given-names>R. M.</given-names></name> <name><surname>Ruscher</surname> <given-names>R.</given-names></name> <name><surname>Giacomin</surname> <given-names>P. R.</given-names></name> <name><surname>Loukas</surname> <given-names>A.</given-names></name></person-group> (<year>2020</year>). <article-title>Harnessing helminth-driven immunoregulation in the search for novel therapeutic modalities</article-title>. <source>PLoS Pathog.</source> <volume>16</volume>:<fpage>e1008508</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1008508</pub-id>, PMID: <pub-id pub-id-type="pmid">32407385</pub-id></citation></ref>
<ref id="ref72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rzepecka</surname> <given-names>J.</given-names></name> <name><surname>Rausch</surname> <given-names>S.</given-names></name> <name><surname>Klotz</surname> <given-names>C.</given-names></name> <name><surname>Schn&#x00F6;ller</surname> <given-names>C.</given-names></name> <name><surname>Kornprobst</surname> <given-names>T.</given-names></name> <name><surname>Hagen</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2009</year>). <article-title>Calreticulin from the intestinal nematode heligmosomoides polygyrus is a Th2-skewing protein and interacts with murine scavenger receptor-A</article-title>. <source>Mol. Immunol.</source> <volume>46</volume>, <fpage>1109</fpage>&#x2013;<lpage>1119</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.molimm.2008.10.032</pub-id>, PMID: <pub-id pub-id-type="pmid">19108896</pub-id></citation></ref>
<ref id="ref73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Samuel</surname> <given-names>C. E.</given-names></name></person-group> (<year>2012</year>). <article-title>ADARs: viruses and innate immunity</article-title>. <source>Curr. Top. Microbiol. Immunol.</source> <volume>353</volume>, <fpage>163</fpage>&#x2013;<lpage>195</lpage>. doi: <pub-id pub-id-type="doi">10.1007/82_2011_148</pub-id>, PMID: <pub-id pub-id-type="pmid">21809195</pub-id></citation></ref>
<ref id="ref74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sang</surname> <given-names>Y.</given-names></name> <name><surname>Miller</surname> <given-names>L. C.</given-names></name> <name><surname>Blecha</surname> <given-names>F.</given-names></name></person-group> (<year>2015</year>). <article-title>Macrophage polarization in virus-host interactions</article-title>. <source>J. Clin. Cell Immunol.</source> <volume>6</volume>:<fpage>311</fpage>. doi: <pub-id pub-id-type="doi">10.4172/2155-9899.1000311</pub-id></citation></ref>
<ref id="ref75"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Santiago-Olivares</surname> <given-names>C.</given-names></name> <name><surname>Rivera-Toledo</surname> <given-names>E.</given-names></name> <name><surname>G&#x00F3;mez</surname> <given-names>B.</given-names></name></person-group> (<year>2019</year>). <article-title>Nitric oxide production is downregulated during respiratory syncytial virus persistence by constitutive expression of arginase 1</article-title>. <source>Arch. Virol.</source> <volume>164</volume>, <fpage>2231</fpage>&#x2013;<lpage>2241</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00705-019-04259-0</pub-id>, PMID: <pub-id pub-id-type="pmid">31177351</pub-id></citation></ref>
<ref id="ref76"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sarmiento</surname> <given-names>R. E.</given-names></name> <name><surname>Tirado</surname> <given-names>R.</given-names></name> <name><surname>G&#x00F3;mez</surname> <given-names>B.</given-names></name></person-group> (<year>2002</year>). <article-title>Characteristics of a respiratory syncytial virus persistently infected macrophage-like culture</article-title>. <source>Virus Res.</source> <volume>84</volume>, <fpage>45</fpage>&#x2013;<lpage>58</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0168-1702(01)00420-8</pub-id>, PMID: <pub-id pub-id-type="pmid">11900838</pub-id></citation></ref>
<ref id="ref77"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schcolnik-Cabrera</surname> <given-names>A.</given-names></name> <name><surname>Ju&#x00E1;rez</surname> <given-names>M.</given-names></name> <name><surname>Oldak</surname> <given-names>B.</given-names></name> <name><surname>Cruz-Rivera</surname> <given-names>M.</given-names></name> <name><surname>Flisser</surname> <given-names>A.</given-names></name> <name><surname>Due&#x00F1;as-Gonz&#x00E1;lez</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title><italic>In vitro</italic> employment of recombinant <italic>Taenia solium</italic> calreticulin as a novel strategy against breast and ovarian cancer stem-like cells</article-title>. <source>Arch. Med. Res.</source> <volume>51</volume>, <fpage>65</fpage>&#x2013;<lpage>75</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.arcmed.2019.12.003</pub-id>, PMID: <pub-id pub-id-type="pmid">32097797</pub-id></citation></ref>
<ref id="ref78"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schroder</surname> <given-names>K.</given-names></name> <name><surname>Tschopp</surname> <given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>The inflammasomes</article-title>. <source>Cell</source> <volume>140</volume>, <fpage>821</fpage>&#x2013;<lpage>832</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2010.01.040</pub-id></citation></ref>
<ref id="ref79"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schwarze</surname> <given-names>J.</given-names></name> <name><surname>O&#x2019;Donnell</surname> <given-names>D. R.</given-names></name> <name><surname>Rohwedder</surname> <given-names>A.</given-names></name> <name><surname>Openshaw</surname> <given-names>P. J. M.</given-names></name></person-group> (<year>2004</year>). <article-title>Latency and persistence of respiratory syncytial virus despite T cell immunity</article-title>. <source>Am. J. Respir. Crit. Care Med.</source> <volume>169</volume>, <fpage>801</fpage>&#x2013;<lpage>805</lpage>. doi: <pub-id pub-id-type="doi">10.1164/rccm.200308-1203OC</pub-id></citation></ref>
<ref id="ref80"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sedeyn</surname> <given-names>K.</given-names></name> <name><surname>Schepens</surname> <given-names>B.</given-names></name> <name><surname>Saelens</surname> <given-names>X.</given-names></name></person-group> (<year>2019</year>). <article-title>Respiratory syncytial virus nonstructural proteins 1 and 2: exceptional disrupters of innate immune responses</article-title>. <source>PLoS Pathog.</source> <volume>15</volume>:<fpage>e1007984</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1007984</pub-id>, PMID: <pub-id pub-id-type="pmid">31622448</pub-id></citation></ref>
<ref id="ref81"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sundaram</surname> <given-names>K.</given-names></name> <name><surname>Rahman</surname> <given-names>M. A.</given-names></name> <name><surname>Mitra</surname> <given-names>S.</given-names></name> <name><surname>Knoell</surname> <given-names>D. L.</given-names></name> <name><surname>Woodiga</surname> <given-names>S. A.</given-names></name> <name><surname>King</surname> <given-names>S. J.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>I&#x03BA;B&#x03B6; regulates human monocyte pro-inflammatory responses induced by <italic>Streptococcus pneumoniae</italic></article-title>. <source>PLoS One</source> <volume>11</volume>:<fpage>e0161931</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0161931</pub-id>, PMID: <pub-id pub-id-type="pmid">27597997</pub-id></citation></ref>
<ref id="ref82"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tabatabai</surname> <given-names>J.</given-names></name> <name><surname>Thielen</surname> <given-names>A.</given-names></name> <name><surname>Lehners</surname> <given-names>N.</given-names></name> <name><surname>Daeumer</surname> <given-names>M.</given-names></name> <name><surname>Schnitzler</surname> <given-names>P.</given-names></name></person-group> (<year>2018</year>). <article-title>Respiratory syncytial virus A in haematological patients with prolonged shedding: premature stop codons and deletion of the genotype ON1 72-nucleotide-duplication in the attachment G gene</article-title>. <source>J. Clin. Virol.</source> <volume>98</volume>, <fpage>10</fpage>&#x2013;<lpage>17</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jcv.2017.11.003</pub-id>, PMID: <pub-id pub-id-type="pmid">29175230</pub-id></citation></ref>
<ref id="ref83"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tom&#x00E9;</surname> <given-names>D.</given-names></name></person-group> (<year>2021</year>). <article-title>Amino acid metabolism and signalling pathways: potential targets in the control of infection and immunity</article-title>. <source>Eur. J. Clin. Nutr.</source> <volume>75</volume>, <fpage>1319</fpage>&#x2013;<lpage>1327</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41430-021-00943-0</pub-id>, PMID: <pub-id pub-id-type="pmid">34163018</pub-id></citation></ref>
<ref id="ref84"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsutsui</surname> <given-names>H.</given-names></name> <name><surname>Matsui</surname> <given-names>K.</given-names></name> <name><surname>Kawada</surname> <given-names>N.</given-names></name> <name><surname>Hyodo</surname> <given-names>Y.</given-names></name> <name><surname>Hayashi</surname> <given-names>N.</given-names></name> <name><surname>Okamura</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>1997</year>). <article-title>IL-18 accounts for both TNF-alpha-and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice</article-title>. <source>J. Immunol.</source> <volume>159</volume>, <fpage>3961</fpage>&#x2013;<lpage>3967</lpage>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.159.8.3961</pub-id>, PMID: <pub-id pub-id-type="pmid">9378984</pub-id></citation></ref>
<ref id="ref85"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tyner</surname> <given-names>J. W.</given-names></name> <name><surname>Uchida</surname> <given-names>O.</given-names></name> <name><surname>Kajiwara</surname> <given-names>N.</given-names></name> <name><surname>Kim</surname> <given-names>E. Y.</given-names></name> <name><surname>Patel</surname> <given-names>A. C.</given-names></name> <name><surname>O&#x2019;Sullivan</surname> <given-names>M. P.</given-names></name> <etal/></person-group>. (<year>2005</year>). <article-title>CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection</article-title>. <source>Nat. Med.</source> <volume>11</volume>, <fpage>1180</fpage>&#x2013;<lpage>1187</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nm1303</pub-id>, PMID: <pub-id pub-id-type="pmid">16208318</pub-id></citation></ref>
<ref id="ref86"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Valdovinos</surname> <given-names>M. R.</given-names></name> <name><surname>G&#x00F3;mez</surname> <given-names>B.</given-names></name></person-group> (<year>2003</year>). <article-title>Establishment of respiratory syncytial virus persistence in cell lines: association with defective interfering particles</article-title>. <source>Intervirology</source> <volume>46</volume>, <fpage>190</fpage>&#x2013;<lpage>198</lpage>. doi: <pub-id pub-id-type="doi">10.1159/000071461</pub-id>, PMID: <pub-id pub-id-type="pmid">12867758</pub-id></citation></ref>
<ref id="ref87"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Velazquez-Salinas</surname> <given-names>L.</given-names></name> <name><surname>Verdugo-Rodriguez</surname> <given-names>A.</given-names></name> <name><surname>Rodriguez</surname> <given-names>L. L.</given-names></name> <name><surname>Borca</surname> <given-names>M. V.</given-names></name></person-group> (<year>2019</year>). <article-title>The role of interleukin 6 during viral infections</article-title>. <source>Front. Microbiol.</source> <volume>10</volume>:<fpage>1057</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2019.01057</pub-id>, PMID: <pub-id pub-id-type="pmid">31134045</pub-id></citation></ref>
<ref id="ref88"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname> <given-names>T.</given-names></name> <name><surname>Adamson</surname> <given-names>A.</given-names></name> <name><surname>Jackson</surname> <given-names>D. A.</given-names></name></person-group> (<year>2013</year>). <article-title>BCL-3 attenuation of TNFA expression involves an incoherent feed-forward loop regulated by chromatin structure</article-title>. <source>PLoS One</source> <volume>8</volume>:<fpage>e77015</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0077015</pub-id>, PMID: <pub-id pub-id-type="pmid">24130828</pub-id></citation></ref>
<ref id="ref89"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>Y.</given-names></name> <name><surname>Zheng</surname> <given-names>J.</given-names></name> <name><surname>Wang</surname> <given-names>X.</given-names></name> <name><surname>Yang</surname> <given-names>P.</given-names></name> <name><surname>Zhao</surname> <given-names>D.</given-names></name></person-group> (<year>2022</year>). <article-title>Alveolar macrophages and airway hyperresponsiveness associated with respiratory syncytial virus infection</article-title>. <source>Front. Immunol.</source> <volume>13</volume>:<fpage>1012048</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2022.1012048</pub-id>, PMID: <pub-id pub-id-type="pmid">36341376</pub-id></citation></ref>
<ref id="ref90"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Winter</surname> <given-names>J. A.</given-names></name> <name><surname>Davies</surname> <given-names>O. R.</given-names></name> <name><surname>Brown</surname> <given-names>A. P.</given-names></name> <name><surname>Garnett</surname> <given-names>M. C.</given-names></name> <name><surname>Stolnik</surname> <given-names>S.</given-names></name> <name><surname>Pritchard</surname> <given-names>D. I.</given-names></name></person-group> (<year>2005</year>). <article-title>The assessment of hookworm calreticulin as a potential vaccine for necatoriasis</article-title>. <source>Parasite Immunol.</source> <volume>27</volume>, <fpage>139</fpage>&#x2013;<lpage>146</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-3024.2005.00756.x</pub-id>, PMID: <pub-id pub-id-type="pmid">15910422</pub-id></citation></ref>
<ref id="ref91"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>P.</given-names></name> <name><surname>Hartert</surname> <given-names>T. V.</given-names></name></person-group> (<year>2011</year>). <article-title>Evidence for a causal relationship between respiratory syncytial virus infection and asthma</article-title>. <source>Expert Rev. Anti-Infect. Ther.</source> <volume>9</volume>, <fpage>731</fpage>&#x2013;<lpage>745</lpage>. doi: <pub-id pub-id-type="doi">10.1586/eri.11.92</pub-id>, PMID: <pub-id pub-id-type="pmid">21905783</pub-id></citation></ref>
<ref id="ref92"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname> <given-names>Z.</given-names></name> <name><surname>Bailey</surname> <given-names>A.</given-names></name> <name><surname>Kuleshov</surname> <given-names>M. V.</given-names></name> <name><surname>Clarke</surname> <given-names>D. J. B.</given-names></name> <name><surname>Evangelista</surname> <given-names>J. E.</given-names></name> <name><surname>Jenkins</surname> <given-names>S. L.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Gene set knowledge discovery with Enrichr</article-title>. <source>Curr. Protoc.</source> <volume>1</volume>:<fpage>e90</fpage>. doi: <pub-id pub-id-type="doi">10.1002/cpz1.90</pub-id></citation></ref>
<ref id="ref93"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>S.</given-names></name> <name><surname>Ge</surname> <given-names>H.</given-names></name> <name><surname>Li</surname> <given-names>S.</given-names></name> <name><surname>Qiu</surname> <given-names>H. J.</given-names></name></person-group> (<year>2022</year>). <article-title>Modulation of macrophage polarization by viruses: turning off/on host antiviral responses</article-title>. <source>Front. Microbiol.</source> <volume>13</volume>:<fpage>13</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2022.839585</pub-id>, PMID: <pub-id pub-id-type="pmid">35222345</pub-id></citation></ref>
</ref-list>
</back>
</article>